Behavioural syndromes associated with physiological disturbances and physical factors

F5_BEHAVE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_ANOREX F5_BULIMIA F5_EATOTH F5_SLEEP F5_SEXDYS F5_MENTPUER F5_ABUNONDEP F5_PHYSBEHOTH	61544
6. Filter based on genotype QC (FinnGen only)	58980

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_BEHAVE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_ANOREX\|F5_BULIMIA\|F5_EATOTH\|F5_SLEEP\|F5_SEXDYS\|F5_MENTPUER\|F5_ABUNONDEP\|F5_PHYSBEHOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Behavioural syndromes associated with physiological disturbances and physical factors based on the number of shared cases.

Similar with more cases:

Psychiatric diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	58980	41750	17230
Unadjusted period prevalence (%)	12.79	14.81	7.89
Median age at first event (years)	50.01	48.35	54.02

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
56350: Matched controls
399425

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F61.0

ICD-10 Finland

Mixed personality disorders

3.8

323.3

1140

2187

P15

ICPC

Chronic alcohol abuse

2.9

322.0

1692

4195

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

320.7

13851

71319

A03

ICPC

Fever

1.6

320.1

9316

43923

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.0

317.5

787

1134

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.8

312.3

5699

23694

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

311.1

3164

10751

R00.2

ICD-10 Finland

Palpitations

2.0

309.4

4129

15520

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.4

307.7

949

1542

N06AB10

ATC

escitalopram; oral

3.0

307.7

16615

48824

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.2

307.7

2672

6149

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.9

307.7

5805

22988

N05AH04

ATC

quetiapine; oral

5.3

307.7

18499

33864

M01AB05

ATC

diclofenac; systemic, rectal

1.5

307.7

34452

204600

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.0

307.7

1970

4706

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.2

307.7

6899

16646

N06AB03

ATC

fluoxetine; oral

2.8

307.7

8541

24023

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.6

307.7

1245

2521

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.2

307.7

9981

19605

F41

ICD-10 Finland

Other anxiety disorders

3.9

307.7

1210

2212

R06AE07

ATC

cetirizine; oral

1.4

307.7

23420

131543

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.5

307.7

1314

2702

A98

ICPC

Health maint/preventive medicine

2.8

307.7

54809

370467

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.5

307.7

1813

3731

F43.8

ICD-10 Finland

Other reactions to severe stress

4.1

307.7

2041

3618

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.4

307.7

2359

5066

N05BA04

ATC

oxazepam; oral

3.3

307.7

19988

57683

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

307.7

3472

11573

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

307.7

1867

4162

J01DB01

ATC

cefalexin; oral

1.6

307.7

44974

284979

N05CD07

ATC

temazepam; oral

2.7

307.7

6497

18411

D11

ICPC

Diarrhoea

2.0

307.7

7180

26830

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

23816

114131

M25.5

ICD-10 Finland

Pain in joint

1.7

307.7

17924

84477

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

23442

124575

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

6.1

307.7

3682

4520

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.6

307.7

1555

3109

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

11.0

307.7

2626

1761

M03BX02

ATC

tizanidine; oral

1.8

307.7

35030

192524

SPAT1283

SPAT

Restricted health certificate

1.9

307.7

11375

47306

M01AH05

ATC

etoricoxib; oral

1.6

307.7

33010

188995

N06AX03

ATC

mianserin; oral

3.9

307.7

3281

6255

F34.1

ICD-10 Finland

Dysthymia

3.5

307.7

2593

5448

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

39.3

307.7

418

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

307.7

3377

11026

P74

ICPC

Anxiety disorder/anxiety state

3.4

307.7

3329

7233

C07AA05

ATC

propranolol; systemic

2.3

307.7

13429

48213

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

30639

175045

N05BA12

ATC

alprazolam; oral

2.4

307.7

5891

18509

R06.0

ICD-10 Finland

Dyspnoea

1.6

307.7

12630

62099

N06AX22

ATC

agomelatine; oral

4.8

307.7

1946

2950

N03AX12

ATC

[U] gabapentin; oral

1.8

307.7

8343

34994

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

12.1

307.7

633

374

N06AX26

ATC

vortioxetine; oral

3.5

307.7

6111

13309

F50.2

ICD-10 Finland

Bulimia nervosa

72.8

307.7

900

KMAK, ,

NOMESCO Finland

1.5

307.7

27564

158317

N02BE01

ATC

paracetamol; systemic, rectal

1.9

307.7

48545

306963

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.6

307.7

11983

56769

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

307.7

5962

18036

N05AX12

ATC

aripiprazole; systemic

2.9

307.7

2747

7050

R42

ICD-10 Finland

Dizziness and giddiness

1.6

307.7

10796

51785

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

307.7

37293

225004

78410

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Emesis

+∞

307.7

379

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.8

307.7

1658

3172

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

307.7

5119

18744

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

307.7

40950

242396

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

46707

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.3

307.7

1597

3552

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.2

307.7

3691

6554

G47.3

ICD-10 Finland

Sleep apnoea

1.7

307.7

11404

52185

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

307.7

9443

40794

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.2

307.7

2629

4606

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.8

307.7

1185

2248

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

307.7

9182

42804

F43.0

ICD-10 Finland

Acute stress reaction

4.0

307.7

4706

8922

L17

ICPC

Foot/toe symptom/complaint

1.5

307.7

14122

72625

SPAT1307

SPAT

Psychosocial counselling and guidance

2.5

307.7

4335

13013

R06AX27

ATC

desloratadine; oral

1.5

307.7

15685

80320

R01AD12

ATC

fluticasone furoate; nasal

1.6

307.7

17590

89251

P76

ICPC

Depressive disorder

3.1

307.7

5124

12401

P29

ICPC

Psychological sympt/compl other

3.0

307.7

5392

13739

D10

ICPC

Vomiting

2.1

307.7

3599

12536

N03AX09

ATC

lamotrigine; oral

2.9

307.7

3340

8365

A02BC05

ATC

esomeprazole; systemic

1.5

307.7

20341

109073

G47.9

ICD-10 Finland

Sleep disorder, unspecified

4.2

307.7

1995

3469

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

114.3

307.7

543

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

307.7

12684

60314

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.2

307.7

1892

4305

P01AB01

ATC

metronidazole; oral, rectal

1.4

307.7

20171

111026

G44.2

ICD-10 Finland

Tension-type headache

2.1

307.7

8380

30590

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

9711

41252

N06AA12

ATC

doxepin; systemic

3.2

307.7

3042

6932

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

307.7

13110

66003

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

307.7

8179

32259

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.9

307.7

2458

4608

F50.8

ICD-10 Finland

Other eating disorders

50.3

307.7

590

P86

ICPC

Anorexia nervosa/bulimia

17.3

307.7

360

148

Z05

ICPC

Work problem

3.2

307.7

1933

4344

N06AB04

ATC

citalopram; systemic

2.4

307.7

13558

45777

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

307.7

29827

171185

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.5

307.7

5428

11862

R51.80

ICD-10 Finland

Headache

2.1

307.7

9769

36215

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.8

307.7

1412

2696

OAB43, ,

SPAT

1.9

307.7

19063

83799

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

89.6

307.7

414

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

26242

146283

Z01.2

ICD-10 Finland

Dental examination

1.4

307.7

24350

139233

N03AE01

ATC

clonazepam; systemic

2.4

307.7

3051

9213

L01

ICPC

Neck symptom/complaint

1.8

307.7

8389

35851

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

4.1

307.7

9373

18676

N06BA04

ATC

methylphenidate; oral

3.1

307.7

2329

5450

N03AX16

ATC

[U] pregabalin

1.8

307.7

12293

53162

R74

ICPC

Upper respiratory infection acute

1.8

307.7

20049

92876

IHZ05, ,

SPAT

2.5

307.7

2461

7041

R01AD58

ATC

fluticasone, combinations; nasal

1.7

307.7

13982

66247

F51

ICD-10 Finland

Nonorganic sleep disorders

6.7

307.7

4543

5197

M54

ICD-10 Finland

Dorsalgia

1.9

307.7

7206

27940

R21

ICPC

Throat symptom/complaint

1.7

307.7

12863

58647

A02BC02

ATC

pantoprazole; systemic

1.6

307.7

35203

204516

Z71.8

ICD-10 Finland

Other specified counselling

1.8

307.7

18193

83047

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

307.7

6612

25694

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

307.7

31712

155120

F43.1

ICD-10 Finland

Post-traumatic stress disorder

3.7

307.7

1973

3917

OAB48, ,

SPAT

1.7

307.7

8140

36503

P03

ICPC

Feeling depressed

2.9

307.7

8041

21488

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.6

307.7

3971

11316

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

4.1

307.7

1537

2735

P02

ICPC

Acute stress reaction

3.4

307.7

4151

9083

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.6

307.7

2079

4213

N06AB06

ATC

sertraline; oral

3.0

307.7

8662

23043

N07BB01

ATC

disulfiram; oral

2.8

307.7

2601

6856

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

45021

286407

N05AH03

ATC

olanzapine; systemic

3.0

307.7

4415

10993

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

3.9

307.7

2032

3813

N06AB05

ATC

paroxetine; oral

2.6

307.7

3695

10420

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.5

307.7

1669

3498

N06AX05

ATC

trazodone; oral

6.5

307.7

2310

2627

J01FA10

ATC

azithromycin; systemic

1.5

307.7

31433

185468

R53

ICD-10 Finland

Malaise and fatigue

2.3

307.7

15256

56441

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

307.7

14643

56296

A04

ICPC

Weakness/tiredness general

2.0

307.7

8375

32526

N04BC05

ATC

pramipexole; oral

2.3

307.7

3790

12329

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.4

307.7

3146

6886

M79.1

ICD-10 Finland

Myalgia

1.9

307.7

8090

32703

G43

ICD-10 Finland

Migraine

2.5

307.7

3337

9869

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

307.7

27664

161378

F33

ICD-10 Finland

Recurrent depressive disorder

4.3

307.7

1777

3005

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.0

307.7

1128

1633

F32.0

ICD-10 Finland

Mild depressive episode

3.3

307.7

1878

4154

N76.0

ICD-10 Finland

Acute vaginitis

2.1

307.7

3670

12718

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

307.7

10769

44666

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

99.8

307.7

308

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

32523

191374

M01AE01

ATC

ibuprofen; systemic, rectal

1.8

307.7

49932

325456

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.6

307.7

1417

2861

N05AA02

ATC

levomepromazine; systemic

3.6

307.7

2584

5284

N05AF03

ATC

chlorprothixene; systemic

3.2

307.7

1558

3501

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.7

307.7

3697

7488

SPAT1240

SPAT

Therapeutic discussion

2.6

307.7

7868

23426

N05BE01

ATC

buspirone; oral

3.2

307.7

1753

3967

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

307.7

21596

101198

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

307.7

23452

118470

N06AX12

ATC

bupropion; oral

3.3

307.7

5855

13521

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

307.7

6418

25787

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

307.7

574

N05CF02

ATC

zolpidem; oral

4.0

307.7

15351

33833

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

21540

96887

D01

ICPC

Abdominal pain/cramps general

1.9

307.7

6616

26688

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

25707

142002

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.7

307.7

2409

4729

R03AC02

ATC

salbutamol; inhalant

1.6

307.7

30407

166230

F43.00

ICD-10 Finland

Acute stress reaction mild

3.2

307.7

1622

3723

N06AX11

ATC

mirtazapine; oral

7.0

307.7

34480

73754

F50.9

ICD-10 Finland

Eating disorder, unspecified

67.8

307.7

1608

173

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.0

307.7

1639

2982

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

7.6

307.7

581

546

L03

ICPC

Low back symptom/complaint

1.7

307.7

15380

71154

P99

ICPC

Psychological disorders other

2.9

307.7

1868

4605

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.8

307.7

1966

3813

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.9

307.7

1098

2025

N06AA09

ATC

amitriptyline; systemic

2.1

307.7

4808

16847

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.7

307.7

3786

7598

N05CF01

ATC

zopiclone; oral

3.7

307.7

24576

68300

R01AD09

ATC

mometasone; nasal

1.5

307.7

24778

135246

N06AA06

ATC

trimipramine; systemic

5.0

307.7

1729

2534

N01

ICPC

Headache

2.0

307.7

7027

26450

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

307.7

15865

82224

OAB93, ,

SPAT

3.3

307.7

4541

10404

N89

ICPC

Migraine

2.7

307.7

2217

6041

Z73.0

ICD-10 Finland

Burn-out

4.7

307.7

3326

5244

OAA65, ,

SPAT

2.7

307.7

12649

38882

OAB91, ,

SPAT

2.6

307.7

4209

12166

F50.0

ICD-10 Finland

Anorexia nervosa

189.9

307.7

1026

P25

ICPC

Phase of life problem adult

2.5

307.7

2611

7685

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

307.7

4028

13583

SFA20

NOMESCO Finland

Two-surface restoration

1.4

307.7

31366

186810

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.6

307.7

1249

2495

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.0

307.7

7517

19714

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.7

307.7

1386

2152

OAA81, ,

SPAT

2.9

307.7

2028

4999

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

307.7

3682

11818

N05BA01

ATC

diazepam; systemic, rectal

2.3

307.7

7624

25153

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

14121

69268

N02AX02

ATC

tramadol; systemic, rectal

1.6

307.7

21526

113446

F32

ICD-10 Finland

Depressive episode

3.7

307.7

4554

9358

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.8

307.7

4591

9065

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.7

307.7

1288

2492

K30

ICD-10 Finland

Functional dyspepsia

1.8

307.7

5778

23743

N03AG01

ATC

valproic acid; systemic, rectal

2.3

307.7

3275

10649

F32.1

ICD-10 Finland

Moderate depressive episode

3.7

307.7

5090

10356

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

14095

60160

P01

ICPC

Feeling anxious/nervous/tense

3.2

307.7

10639

27372

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.5

307.7

2053

4220

P06

ICPC

Sleep disturbance

4.8

307.7

11792

20780

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.5

307.7

1833

3853

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

4622

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

307.7

12844

56290

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.6

307.7

11580

26601

SFA10

NOMESCO Finland

One-surface restoration

1.4

307.7

29439

173566

N06AX16

ATC

venlafaxine; oral

3.0

307.7

11213

30083

ZY010

NOMESCO Finland

Hospital outpatient

2.7

307.7

3373

9166

R83

ICPC

Respiratory infection other

1.6

307.7

15156

73787

R51

ICD-10 Finland

Headache

2.3

307.7

3317

10699

F50.3

ICD-10 Finland

Atypical bulimia nervosa

66.3

307.7

647

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

307.7

39147

237286

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

307.7

15089

71824

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.7

307.7

4640

9505

N06AX21

ATC

duloxetine; oral

2.6

307.7

7957

23345

J02AC01

ATC

fluconazole; systemic

1.6

307.7

21177

111230

F50.1

ICD-10 Finland

Atypical anorexia nervosa

104.8

307.7

773

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

307.7

14098

64669

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.9

307.7

2799

7169

Z2445

NOMESCO Finland

Psychologist

2.5

307.7

2354

6802

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

301.5

3924

14616

N06AG02

ATC

moclobemide; oral

2.5

300.5

2201

6482

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.6

299.2

1099

2171

N02BF02

ATC

pregabalin; oral

2.2

298.7

3018

10224

R11

ICD-10 Finland

Nausea and vomiting

1.9

298.4

4394

17067

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

295.9

4703

18723

R05

ICPC

Cough

1.5

292.9

11964

60703

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

292.5

10925

54386

J01AA02

ATC

doxycycline; systemic

1.4

291.9

39370

247321

F40.1

ICD-10 Finland

Social phobias

2.9

291.3

1580

3986

N05AX08

ATC

risperidone; systemic

2.0

290.5

3857

14461

L02

ICPC

Back symptom/complaint

1.8

289.6

5263

21826

F43.29

ICD-10 Finland

Adaptation disorder UNS

3.0

289.2

1410

3345

X23

ICPC

Fear sexually transm dis female

2.1

288.5

2942

9999

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.5

285.4

2086

6135

F43.01

ICD-10 Finland

Acute stress reaction moderate

3.6

284.9

1059

2109

Z01.7

ICD-10 Finland

Laboratory examination

1.6

284.8

7205

32718

R05

ICD-10 Finland

Cough

1.5

283.0

10325

51090

F43.2

ICD-10 Finland

Adjustment disorders

3.5

282.2

1101

2267

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

281.5

2048

6010

-1, ,

NOMESCO Finland

1.4

280.7

17593

96766

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

278.0

2714

9061

R52.9

ICD-10 Finland

Pain, unspecified

1.8

276.5

4924

20282

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

272.7

3824

14596

-1, ,

ICD-10 Finland

2.2

272.4

2612

8655

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

2.0

271.9

3481

12876

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.9

270.5

3871

14874

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.7

270.4

980

1917

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

267.8

27197

161773

SPAT1243

SPAT

Psychiatric/psychological examination

2.7

266.7

1663

4520

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.1

264.5

1245

2891

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

260.6

36271

226424

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

260.5

21352

122502

J01CA08

ATC

pivmecillinam; oral

1.4

257.8

20091

114258

Z2446

NOMESCO Finland

Social worker

2.0

254.9

3253

12011

N05AN01

ATC

lithium; oral

2.9

253.9

1371

3448

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

252.5

11561

59751

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.2

252.2

1134

2560

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.4

249.7

1004

2109

SPAT1308

SPAT

Sexual health counselling

1.6

249.3

6544

29915

A01

ICPC

Pain general/multiple sites

1.8

249.1

4311

17578

D09

ICPC

Nausea

2.1

248.4

2589

8864

Z3231

NOMESCO Finland

Registered nurse

1.4

248.0

12784

67543

S06.0

ICD-10 Finland

Concussion

1.7

247.3

5330

23146

R01AD08

ATC

fluticasone; nasal

1.4

247.0

14276

77006

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

246.8

21000

120884

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

246.3

9878

49678

Z2221

NOMESCO Finland

Medical doctor

1.4

243.2

13099

69725

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

242.6

6247

28407

N30.0

ICD-10 Finland

Acute cystitis

1.6

241.8

7827

37573

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.9

241.5

1280

3185

D73

ICPC

Gastroenteritis presumed infection

2.3

241.5

1979

6128

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

240.3

4563

19115

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

239.9

10177

51734

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.5

239.7

921

1876

M54.2

ICD-10 Finland

Cervicalgia

1.8

239.7

3859

15382

P58

ICPC

Psychological, Therapeutic counselling/listening

3.0

239.7

1216

2951

F32.8

ICD-10 Finland

Other depressive episodes

3.3

237.5

986

2115

A02BC01

ATC

omeprazole; systemic

1.4

237.1

12458

65962

SPAT1051

SPAT

Guidance regarding sleep disorders

3.4

236.9

942

1964

M79.7

ICD-10 Finland

Fibromyalgia

2.4

236.4

1838

5557

N06AB08

ATC

fluvoxamine; oral

2.8

236.2

1357

3530

A02BC03

ATC

lansoprazole; oral

1.4

235.8

12827

68336

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

234.8

1195

2905

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.8

234.6

3811

15230

E66.8

ICD-10 Finland

Other obesity

2.0

233.5

2864

10418

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

233.3

3938

15923

N02BF01

ATC

gabapentin; oral

1.8

233.2

3818

15293

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.1

233.0

1099

2554

N30

ICD-10 Finland

Cystitis

1.8

232.1

4082

16712

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

231.3

12924

69144

GD1AA, ,

SPAT

1.6

229.9

6047

27615

L12

ICPC

Hand/finger symptom/complaint

1.5

229.9

7904

38414

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

229.7

8743

43422

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

229.6

5514

24611

R03DC03

ATC

montelukast; oral

1.5

229.0

8094

39569

J45

ICD-10 Finland

Asthma

1.7

228.8

5062

22112

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

227.6

3707

14821

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.6

226.8

5843

26543

F51.1

ICD-10 Finland

Nonorganic hypersomnia

26.1

226.4

202

L08

ICPC

Shoulder symptom/complaint

1.5

225.8

9988

51114

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

225.8

5855

26637

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.5

224.8

879

1812

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

224.6

10721

55670

F31

ICD-10 Finland

Bipolar affective disorder

3.7

224.5

794

1526

O99.80

ICD-10 Finland

The fear of childbirth

2.1

224.3

2315

7889

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.6

223.9

845

1700

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

223.7

5692

25769

K08.80

ICD-10 Finland

Toothache NOS

1.7

223.1

4501

19163

R52.2

ICD-10 Finland

Other chronic pain

2.3

221.9

1817

5622

R12

ICD-10 Finland

Heartburn

1.8

221.1

3949

16233

P16

ICPC

Acute alcohol abuse

3.3

220.9

942

2056

IBZ05

NOMESCO Finland

Evaluation of patient with eating disorder

110.2

220.1

155

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

220.1

3674

14796

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

218.5

14832

81903

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.6

218.3

821

1648

K59.0

ICD-10 Finland

Constipation

2.0

218.2

2536

9041

A05

ICPC

Feeling ill

1.8

217.3

3390

13366

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

215.0

5500

24918

R02

ICPC

Shortness of breath/dyspnoea

1.6

213.6

5891

27183

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

213.2

20184

117314

E0000UV, ,

ATC

1.3

212.5

20641

120411

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.5

211.4

592

949

N02CC07

ATC

frovatriptan; oral

2.2

210.7

2107

7088

J20

ICD-10 Finland

Acute bronchitis

1.7

210.3

4874

21526

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

209.8

2933

11153

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

209.7

5703

26218

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

209.4

7074

34183

G03DB01

ATC

dydrogesterone; oral

1.6

208.6

5976

27816

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

208.5

19294

111650

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

206.5

2563

9353

N05AB03

ATC

perphenazine; systemic, rectal

2.3

206.4

1683

5195

N05BA02

ATC

chlordiazepoxide; systemic

2.9

205.8

1103

2761

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

205.5

5278

23922

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.9

205.2

3045

11807

T74.1

ICD-10 Finland

Physical abuse

2.8

204.3

1117

2827

SPAT1310

SPAT

Counselling related to known health issue

1.4

201.8

15290

85709

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

199.3

2818

10753

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

198.7

8349

42175

H01

ICPC

Ear pain/earache

1.6

197.3

5846

27401

R07.0

ICD-10 Finland

Pain in throat

1.8

196.3

3614

14969

D82

ICPC

Teeth/gum disease

1.3

196.0

18867

109535

J01DA01

ATC

[U] cefalexin

1.3

196.0

30672

190530

E66

ICD-10 Finland

Obesity

1.9

195.2

2576

9601

R07

ICPC

Sneezing/nasal congestion

1.8

195.1

3452

14130

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

194.9

914

2116

SGA01

NOMESCO Finland

Emergency treatment

1.5

193.7

8152

41169

Z00.0

ICD-10 Finland

General medical examination

1.4

193.7

9039

46569

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.2

192.7

858

1924

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.3

192.2

832

1833

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.2

192.2

856

1920

F41.00

ICD-10 Finland

Moderate panic disorder

3.0

191.9

926

2181

ZXE00

NOMESCO Finland

One hour or less

1.3

191.5

18275

105868

F53.0

ICD-10 Finland

Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified

22.3

191.0

179

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

190.6

9921

52130

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

189.5

3861

16453

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

6.9

189.3

342

355

Z3226

NOMESCO Finland

Physiotherapist

1.5

188.0

8054

40793

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

187.0

3883

16631

EBA00

NOMESCO Finland

Extraction of tooth

1.3

186.9

17654

102028

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

186.8

11476

62035

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.7

186.4

662

1276

R07.3

ICD-10 Finland

Other chest pain

1.6

186.1

4515

20146

H02AB06

ATC

prednisolone; systemic

1.3

185.5

22267

133037

N03AX11

ATC

topiramate; oral

2.5

185.0

1309

3783

F60.5

ICD-10 Finland

Anankastic personality disorder

3.6

183.6

673

1327

F10.24

ICD-10 Finland

Alcohol depence active use

3.2

182.9

805

1792

U02

ICPC

Urinary frequency/urgency

1.5

182.2

6411

31177

J01EA01

ATC

trimethoprim; systemic

1.4

182.2

11810

64367

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.0

181.1

588

1061

W12

ICPC

Contraception intrauterine

1.6

181.0

4540

20420

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

180.9

14913

84383

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.0

180.8

899

2155

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

180.5

8317

42684

SPAT1192

SPAT

Gynaecological examination

1.6

179.3

4627

20957

SPAT1312

SPAT

General health counselling

1.3

178.6

15586

88899

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

178.6

2689

10464

Z30.0

ICD-10 Finland

General counselling and advice on contraception

1.8

178.3

2991

12040

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

178.0

4216

18688

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.6

177.9

651

1282

D06

ICPC

Abdominal pain localized other

1.7

177.3

4146

18316

N06BA12

ATC

lisdexamfetamine; oral

3.8

176.8

611

1155

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

176.7

2990

12066

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.7

176.3

618

1180

P18

ICPC

Medication abuse

5.1

175.6

418

580

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

175.3

4891

22566

SPAT1263

SPAT

Sampling

1.3

175.3

20427

121257

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

175.0

2412

9117

N17

ICPC

Vertigo/dizziness

1.6

174.7

5281

24823

L15

ICPC

Knee symptom/complaint

1.4

173.8

10837

58620

SDA03

NOMESCO Finland

Periodontal treatment

1.3

172.9

19810

117259

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.9

172.0

918

2292

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.8

171.7

964

2475

R06AX22

ATC

ebastine; oral

1.4

171.5

8136

41940

J01FA06

ATC

roxithromycin; oral

1.3

171.3

18411

108001

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

171.2

4448

20168

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

170.2

3349

14119

S18

ICPC

Laceration/cut

1.3

170.1

20743

123728

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.4

169.8

9188

48487

D19

ICPC

Teeth/gum symptom/complaint

1.3

169.8

13913

78502

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.1

169.1

1839

6385

EB1AA, ,

SPAT

1.7

169.0

3169

13177

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

167.4

6473

32060

SFA30

NOMESCO Finland

Three-surface restoration

1.3

167.3

20068

119361

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

166.3

6114

29966

A02BC04

ATC

rabeprazole; oral

1.6

164.6

3941

17503

K04.0

ICD-10 Finland

Pulpitis

1.6

163.6

4656

21565

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

163.6

4435

20307

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.4

163.6

467

761

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

163.3

1634

5492

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.6

162.6

1060

2942

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

162.6

2126

7889

M01AC06

ATC

meloxicam; systemic, rectal

1.3

162.0

16110

93315

78419

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Nausea NUD

+∞

161.7

178

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

161.5

3724

16375

K58

ICD-10 Finland

Irritable bowel syndrome

2.3

160.9

1350

4217

IER01

NOMESCO Finland

Psychoeducation, group

4.4

160.0

458

748

K07.60

ICD-10 Finland

Snapping jaw

1.8

159.6

2572

10218

78450

ICD-8 Finland

Symptoms referable to upper gastro-intestinal tract, Haematemesis

+∞

159.0

175

ZY000

NOMESCO Finland

Hospital inpatient

3.1

158.9

736

1691

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.5

158.9

1073

3031

N02CC04

ATC

rizatriptan; oral

1.8

158.5

2724

11036

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

158.3

12549

70321

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.0

158.3

786

1883

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

158.2

8876

47067

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

158.1

3638

15986

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

158.1

10005

54132

H03AA01

ATC

levothyroxine sodium; systemic

1.4

158.0

10403

56646

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.7

157.4

924

2430

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

157.1

3613

15874

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

156.9

2656

10710

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.4

155.4

10152

55187

K04.08

ICD-10 Finland

Other specified pulpit

1.6

155.0

3731

16582

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

154.6

3883

17442

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

154.4

5312

25649

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

154.0

16174

94234

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.6

153.5

4170

19090

WX110, ,

SPAT

1.7

153.4

2848

11800

J01

ICD-10 Finland

Acute sinusitis

1.8

153.3

2656

10783

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

152.7

3967

17964

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

152.7

3544

15602

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.8

152.7

2810

11612

B02AA02

ATC

tranexamic acid; systemic

1.5

152.3

6624

33526

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.7

152.2

3004

12663

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.8

152.2

851

2180

G43.3

ICD-10 Finland

Complicated migraine

2.7

152.1

904

2393

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.8

152.0

525

992

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

151.7

2639

10727

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

151.5

5035

24127

R03BA05

ATC

fluticasone; inhalant

1.4

150.4

8456

44814

N05CD02

ATC

nitrazepam; oral

3.2

150.3

669

1500

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

150.1

15853

92361

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.0

149.9

479

854

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

149.8

3191

13733

AA1AD

NOMESCO Finland

CT of head and brain

1.3

149.7

11031

61054

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

149.1

2027

7619

U01

ICPC

Dysuria/painful urination

1.6

149.1

3577

15879

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.6

149.0

3597

15992

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

148.7

3629

16178

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

148.3

2697

11104

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.9

148.3

2226

8644

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

148.2

2254

8790

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

148.0

5187

25130

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

53.5

147.9

113

F50

ICD-10 Finland

Eating disorders

26.0

147.8

132

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

147.3

3211

13903

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.3

146.9

1295

4131

S29

ICPC

Skin symptom/complaint other

1.4

146.4

8415

44743

L16

ICPC

Ankle symptom/complaint

1.5

145.7

5258

25624

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

145.6

12843

72933

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.9

144.7

2042

7771

M54.8

ICD-10 Finland

Other dorsalgia

1.9

144.0

2075

7950

N02CC03

ATC

zolmitriptan; nasal, oral

1.8

144.0

2507

10190

N02CC05

ATC

almotriptan; oral

1.9

143.3

1901

7085

R03BA02

ATC

budesonide; inhalant

1.4

142.5

8080

42839

W11

ICPC

Contraception oral

1.5

142.1

4556

21644

SPAT1260

SPAT

Consultation of another employee

1.4

141.5

7853

41481

A97

ICPC

No disease

1.4

140.7

8065

42829

SPAT1301

SPAT

No procedures

1.3

140.5

14203

82106

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

140.3

15650

91648

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

140.2

2355

9468

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.3

139.8

598

1308

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

4.1

139.6

436

764

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.8

139.5

2477

10124

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

139.4

16858

99725

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.3

139.1

590

1283

R09

ICPC

Sinus symptom/complaint

1.6

139.0

3870

17801

M77.4

ICD-10 Finland

Metatarsalgia

1.7

138.9

2716

11412

R30.0

ICD-10 Finland

Dysuria

1.9

138.9

1899

7150

W14

ICPC

Contraception female other

1.8

138.9

2429

9884

A02BA02

ATC

ranitidine; systemic

1.4

137.8

7570

39900

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

136.6

4116

19279

J01AA07

ATC

tetracycline; systemic

1.4

136.0

6933

36063

R06.5

ICD-10 Finland

Mouth breathing

1.6

135.9

3884

17973

H92.0

ICD-10 Finland

Otalgia

1.7

135.7

2879

12367

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.7

135.5

824

2207

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

34.6

135.0

112

X58

ICD-10 Finland

Exposure to other specified factors

1.4

134.7

6581

33969

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

134.4

9109

49659

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

134.2

17116

101807

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.2

134.2

266

307

R4110

NOMESCO Finland

Physiotherapy

1.3

134.1

11955

67856

N02CC06

ATC

eletriptan; oral

2.0

133.8

1711

6295

C09CA06

ATC

candesartan; oral

1.3

133.0

10242

56914

T82

ICPC

Obesity

1.9

133.0

1901

7263

S80.0

ICD-10 Finland

Contusion of knee

1.6

132.5

3424

15466

G01AA10

ATC

clindamycin; vaginal

1.4

132.3

6345

32632

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

131.5

13394

77371

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.4

131.4

6179

31662

R35

ICD-10 Finland

Polyuria

1.7

130.6

2575

10841

J05AB01

ATC

aciclovir; systemic

1.3

130.3

9693

53568

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.1

130.2

1369

4688

R06AE09

ATC

levocetirizine; oral

1.4

129.6

6714

34999

OAA67, ,

SPAT

1.4

129.3

7184

37899

A11

ICPC

Chest pain NOS

1.6

129.1

3290

14807

X15

ICPC

Vaginal symptom/complaint other

1.9

129.1

1815

6895

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

128.9

1941

7540

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

128.9

2835

12293

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.7

128.5

2875

12522

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

128.2

11197

63308

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

123.2

127.9

156

J01FA09

ATC

clarithromycin; systemic

1.3

127.9

14585

85432

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.5

127.9

4077

19325

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

3.6

127.8

478

956

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.9

127.8

687

1722

ULA02

NOMESCO Finland

Kolposcopy

1.5

127.8

4174

19888

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

127.7

13335

77228

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

127.5

2986

13158

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.6

126.7

3789

17705

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.8

126.3

719

1860

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

126.3

2089

8356

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

5.4

126.1

284

374

SPAT1389

SPAT

Visit based on need for special support

2.2

126.1

1212

4006

D07AC01

ATC

betamethasone; topical

1.3

125.9

16261

96686

R06AX13

ATC

loratadine; oral

1.4

125.4

7012

37013

IGY02, ,

SPAT

2.9

125.1

646

1583

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

125.0

6401

33283

Z12

ICPC

Relationship problem with partner

2.5

124.7

880

2539

D12

ICPC

Constipation

2.0

124.5

1433

5077

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.5

124.4

4190

20091

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

123.9

3403

15588

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

123.7

12183

69960

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

123.5

4528

22099

N92.5

ICD-10 Finland

Other specified irregular menstruation

2.0

123.1

1505

5449

R50.9

ICD-10 Finland

Fever, unspecified

1.4

123.1

6486

33885

N07BA03

ATC

varenicline; oral

1.8

123.1

2190

8951

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.0

123.0

393

701

J35.0

ICD-10 Finland

Chronic tonsillitis

1.7

122.2

2552

10910

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

122.2

4465

21774

F93.89

ICD-10 Finland

Other childhood emotional disorders

3.6

122.0

449

888

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

121.9

6465

33806

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

121.9

5392

27293

R03BA01

ATC

beclometasone; inhalant

1.4

121.9

5933

30561

LCH11

NOMESCO Finland

Pharmacologic abortion

1.9

121.7

1701

6448

IHZ04, ,

SPAT

2.9

121.2

620

1511

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.3

121.0

963

2938

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

120.7

13271

77262

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

120.5

4110

19754

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.5

120.5

3970

18942

R03AC03

ATC

terbutaline; inhalant

1.4

120.1

6119

31770

X14

ICPC

Vaginal discharge

2.2

120.0

1119

3653

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.1

119.9

552

1264

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

3.8

119.3

405

756

G03HB01

ATC

cyproterone and estrogen; oral

1.5

118.7

4332

21114

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

118.4

13077

76141

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

118.2

4012

19260

R01AD01

ATC

beclometasone; nasal

1.4

118.0

6622

34945

D02

ICPC

Abdominal pain epigastric

1.6

117.7

2694

11797

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

117.6

16606

99590

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.5

117.4

4108

19846

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

117.2

3567

16722

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

117.2

2617

11386

N05AB01

ATC

dixyrazine; systemic

3.1

117.1

533

1212

G02BA03

ATC

plastic IUD with progestogen

1.4

117.1

5038

25359

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

5.0

116.6

288

414

M01AH01

ATC

celecoxib; oral

1.4

116.6

7314

39300

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

116.6

11633

66831

Z63.4

ICD-10 Finland

Disappearance and death of family member

3.0

116.3

568

1348

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

116.2

18407

111807

P19

ICPC

Drug abuse

3.1

116.0

538

1238

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

4.4

115.9

330

537

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.8

115.9

1816

7141

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

115.7

1845

7294

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

115.7

3387

15738

Z29

ICPC

Social problem NOS

2.3

115.7

989

3113

IEY01

NOMESCO Finland

Psychoeducation, individual

3.4

115.5

455

943

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.5

115.4

774

2179

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.7

115.0

2143

8873

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

114.8

902

2736

P27

ICPC

Fear of mental disorder

2.8

113.9

650

1684

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

113.6

8709

48223

EMB10

NOMESCO Finland

Tonsillectomy

1.6

113.5

2813

12564

SPAT1238

SPAT

Brief therapy

2.3

113.4

907

2773

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

112.3

3046

13904

XQ800

NOMESCO Finland

Prick test

1.5

112.1

3379

15801

F52.2

ICD-10 Finland

Failure of genital response

2.5

111.9

797

2310

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

47.5

111.6

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

3.8

111.6

387

734

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

111.5

8273

45575

A99

ICPC

Disease/condition unspecnature/site

1.5

111.2

3801

18265

Z00.8

ICD-10 Finland

Other general examinations

1.5

111.1

3474

16376

L11

ICPC

Wrist symptom/complaint

1.5

110.5

4019

19561

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

110.4

2504

10934

F51.5

ICD-10 Finland

Nightmares

16.0

109.9

117

SGC10

NOMESCO Finland

Pulp capping

1.5

109.8

4191

20598

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

109.7

4918

24928

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

109.4

2162

9100

U07

ICPC

Urine symptom/complaint other

1.6

109.4

2929

13326

N06AA04

ATC

clomipramine; systemic

2.5

109.2

745

2115

L20.0

ICD-10 Finland

Besnier prurigo

1.5

108.6

3454

16341

K04

ICPC

Palpitations/awareness of heart

1.7

108.5

2205

9352

H01.0

ICD-10 Finland

Blepharitis

1.6

108.3

2907

13234

H57.1

ICD-10 Finland

Ocular pain

1.8

108.2

1672

6545

3071A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Anorexia nervosa

+∞

108.1

119

R52.0

ICD-10 Finland

Acute pain

1.9

108.0

1458

5462

OAA62, ,

SPAT

1.5

108.0

3403

16066

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

3.2

107.9

484

1091

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

3.7

107.9

377

719

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

107.8

9311

52387

N06AX18

ATC

reboxetine; oral

3.0

107.6

518

1219

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

107.5

1512

5743

ZYC01, ,

SPAT

1.5

107.3

4370

21747

D07AA02

ATC

hydrocortisone; topical

1.4

107.3

6321

33584

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

107.0

3246

15197

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.3

106.7

452

983

N94.4

ICD-10 Finland

Primary dysmenorrhoea

2.3

106.5

925

2931

ZYC02, ,

SPAT

1.9

106.4

1460

5499

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

1.6

106.3

2837

12895

K05.22

ICD-10 Finland

Acute pericoronitis

1.7

105.8

2217

9480

K03.80

ICD-10 Finland

Irradiated enamel

1.7

105.4

2383

10396

M75.8

ICD-10 Finland

Other shoulder lesions

1.8

105.1

1635

6413

T05

ICPC

Feeding problem of adult

3.2

104.9

473

1070

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

2.1

104.7

1079

3666

J04.0

ICD-10 Finland

Acute laryngitis

1.8

104.7

1655

6524

G44.8

ICD-10 Finland

Other specified headache syndromes

2.5

104.3

725

2077

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.5

104.2

4217

20956

J30.19

ICD-10 Finland

Pollen allergy UNS

1.8

104.1

1796

7270

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

104.0

1147

3999

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

103.7

3411

16250

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

103.5

1395

5222

IGY99, ,

SPAT

2.3

103.5

847

2616

A06AD11

ATC

lactulose; oral

1.4

103.2

5189

26832

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

103.2

4398

22071

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.2

103.1

446

983

L13

ICPC

Hip symptom/complaint

1.3

103.0

7164

39044

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.1

102.8

477

1098

DM1QA, ,

SPAT

1.8

102.6

1664

6611

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

102.5

2037

8585

SPAT1254

SPAT

Administration of medicine

1.4

102.3

6212

33147

UJF32

NOMESCO Finland

Coloscopy

1.3

102.2

10597

61021

M54.3

ICD-10 Finland

Sciatica

1.6

101.9

2428

10732

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

101.9

1547

6021

A23

ICPC

Risk factor NOS

1.5

101.8

3947

19448

E61.1

ICD-10 Finland

Iron deficiency

2.1

101.7

1112

3864

F60.8

ICD-10 Finland

Other specific personality disorders

3.6

101.6

376

747

Z72.2

ICD-10 Finland

Drug use

3.9

101.4

334

610

V03AA01, ,

ATC

2.6

101.2

646

1775

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

101.0

1463

5609

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

101.0

3471

16687

X02

ICPC

Menstrual pain

2.0

100.7

1180

4207

WZC00, ,

SPAT

1.4

100.4

4473

22629

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

100.0

4836

24829

AA400

NOMESCO Finland

Electroconvulsive therapy

3.3

99.9

425

927

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

99.8

11201

65107

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

99.5

4805

24662

J01FF01

ATC

clindamycin; systemic

1.3

99.1

11853

69419

Z3232

NOMESCO Finland

Midwife

1.5

99.0

3291

15708

C07AB07

ATC

bisoprolol; oral

1.2

98.9

19362

119705

H93.1

ICD-10 Finland

Tinnitus

1.6

98.0

2805

12953

IGV01

NOMESCO Finland

Psychiatric network contact

2.9

98.0

504

1233

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.7

97.6

346

667

Z64.0

ICD-10 Finland

Problems related to unwanted pregnancy

2.1

97.6

1028

3522

N06AA10

ATC

nortriptyline; systemic

2.2

97.4

903

2941

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

13487

69043

1.51

321.26

1.8

0.89

1.18

mg/l

24.80

9893

52257

(3018010) Neutrophils/100 leukocytes in Blood

26510

154185

1.41

321.11

5.6

6.0

56.24

56.89

17.18

25007

145239

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

23523

134002

1.42

320.08

5.5

6.0

1.21

mmol/l

2.50

21702

122561

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4136

15481

1.96

313.90

2.4

2.3

6065.59

6066.86

u/l

0.00

1485

6290

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

48639

317735

1.62

313.08

4.2

4.1

1.46

1.47

mmol/l

1.75

45793

296574

(3019069) Monocytes/100 leukocytes in Blood

26043

151478

1.41

311.71

6.0

6.5

8.26

8.47

22.47

24516

142409

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

48916

320071

1.63

311.47

4.2

4.1

4.70

4.72

mmol/l

2.59

46183

299909

(3006504) Eosinophils/100 leukocytes in Blood

25908

150601

1.41

310.86

5.7

6.2

2.84

2.85

0.02

24336

141349

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6527

28285

1.72

309.56

2.0

2.2

374.59

375.39

nmol/l

0.12

5961

26149

(3013826) Glucose [Moles/volume] in Serum or Plasma

30273

180917

1.40

307.98

4.6

6.43

6.66

mmol/l

62.53

28305

167594

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

48225

303895

1.87

307.65

12.2

11.8

88.23

84.74

ml/min/173m2

218.50

40246

248716

(1001926) Buprenorphine [Presence] in Urine by Screen method

4004

11743

2.53

307.65

2.8

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5771

21312

2.02

307.65

2.1

1.8

—

(3044889) 12 lead EKG panel

36053

214726

1.53

307.65

3.6

3.5

—

(3013115) Eosinophils [#/volume] in Blood

28869

165602

1.48

307.65

5.8

6.3

0.19

e9/l

0.34

25492

146388

(3006315) Basophils [#/volume] in Blood

27992

160160

1.47

307.65

5.6

6.1

0.04

e9/l

0.12

24401

139669

(3002385) Erythrocyte distribution width [Ratio]

45197

287860

1.57

307.65

16.4

15.2

14.81

14.92

0.25

44578

282714

(3013650) Neutrophils [#/volume] in Blood by Automated count

31432

184685

1.47

307.65

7.9

9.2

4.03

4.06

e9/l

2.18

27510

161954

(46235355) HIV 1 and 2 tests - Meaningful Use set

14508

71600

1.59

307.65

2.1

1.9

—

(3010813) Leukocytes [#/volume] in Blood

55320

371771

4.00

307.65

21.0

18.7

6.70

6.69

e9/l

0.41

54326

361389

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

18166

96745

1.49

307.65

2.7

2.5

58.24

61.90

u/l

1.60

16734

89495

(3015736) pH of Urine

22798

127382

1.45

307.65

3.3

3.2

5.91

5.88

0.83

2167

10595

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

19624

104918

1.50

307.65

3.2

31.71

33.18

u/l

1.83

18605

99615

(3009542) Hematocrit [Volume Fraction] of Blood

55261

370947

3.90

307.65

21.0

18.8

40.65

40.60

0.17

53138

348873

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

53481

349641

2.65

307.65

10.3

9.7

26.87

26.68

u/l

0.77

52157

338103

(40761511) CBC panel - Blood by Automated count

53019

344623

2.53

307.65

13.0

11.9

—

(3024731) MCV [Entitic volume]

55311

371686

3.97

307.65

20.9

18.6

90.60

90.55

2.31

54884

366825

(3026361) Erythrocytes [#/volume] in Blood

55315

371728

3.98

307.65

21.0

18.7

4.52

4.53

e12/l

3.23

54310

361409

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

15874

74274

1.72

307.65

1.4

1.3

1.27

1.79

u/ml

7.63

4546

20068

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10760

42676

1.97

307.65

2.3

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

4805

15466

2.31

307.65

2.6

2.0

—

(3019198) Lymphocytes [#/volume] in Blood

28818

165238

1.48

307.65

5.6

6.1

1.99

1.94

e9/l

3.86

25670

147380

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

45868

288552

1.68

307.65

5.2

38.27

39.25

mmol/mol

97.28

43236

268837

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

49638

324760

1.70

307.65

4.7

4.5

2.81

mmol/l

0.13

46755

302657

(3000963) Hemoglobin [Mass/volume] in Blood

55322

371871

3.99

307.65

21.1

18.8

135.95

136.02

g/l

0.56

54903

367049

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

25841

148174

1.44

307.65

5.9

6.7

1.22

mmol/l

1.76

22069

125984

(3015377) Calcium [Moles/volume] in Serum or Plasma

19113

99778

1.54

307.65

2.7

3.4

2.35

mmol/l

1.49

17093

88301

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

51691

328916

2.38

307.65

14.0

12.8

19.72

22.90

mg/l

93.63

41502

256580

(3020564) Creatinine [Moles/volume] in Serum or Plasma

53272

347430

2.59

307.65

15.2

14.6

73.09

75.25

umol/l

53.46

53257

347286

(3001122) Ferritin [Mass/volume] in Serum or Plasma

29069

141462

1.94

307.65

3.1

2.8

94.25

117.72

ug/l

50.62

27403

131863

(1002224) Polysomnography panel

3804

13155

2.13

307.65

1.1

—

(3016879) Cocaine [Presence] in Urine

4573

14319

2.38

307.65

2.7

2.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

36681

220543

1.51

307.65

4.4

4.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

40082

232133

1.78

307.65

3.8

3.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

38439

223103

1.70

307.65

3.4

2.9

42.84

45.48

u/l

7.05

36424

209971

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

50238

298440

2.78

307.65

5.5

4.6

1.90

2.10

mu/l

1.71

47593

275905

(3023323) Follitropin [Units/volume] in Serum or Plasma

4681

16542

2.10

307.65

1.4

1.3

25.03

27.09

iu/l

3.87

4002

14215

(3009261) Glucose [Presence] in Urine by Test strip

27442

159018

1.44

307.65

3.6

3.5

0.00

estimate

0.20

5505

28918

(3027944) Amphetamines [Presence] in Urine

4715

15357

2.28

307.65

2.5

1.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

27665

158971

1.46

307.65

5.1

6.1

10.50

11.22

umol/l

17.98

26070

150584

(3019550) Sodium [Moles/volume] in Serum or Plasma

51483

328513

2.28

307.65

15.2

14.4

139.52

139.66

mmol/l

33.34

50492

319992

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

14360

68124

1.66

307.65

1.8

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

35449

208402

1.55

307.65

4.7

4.2

1167.68

1456.77

e6/l

0.45

461

2776

(40760892) CBC W Ordered Manual Differential panel - Blood

26561

150864

1.47

307.65

5.9

6.6

—

(3027008) Opiates [Presence] in Urine

4815

15593

2.30

307.65

2.5

2.0

—

(3035941) MCH [Entitic mass]

55312

371643

3.98

307.65

20.9

18.6

30.24

30.19

9.51

54888

366793

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

40522

240271

1.70

307.65

6.9

7.4

74.28

77.55

u/l

51.30

38395

226848

(3002030) Lymphocytes/100 leukocytes in Blood

26873

156540

1.41

307.65

5.7

6.2

29.29

28.46

31.20

25369

147572

(3035350) Ketones [Presence] in Urine by Test strip

27274

157310

1.44

307.65

3.6

3.5

0.00

estimate

0.70

5740

31124

(3028707) Methadone [Presence] in Urine by Screen method

2731

5883

3.41

307.65

3.2

2.9

—

(3007461) Platelets [#/volume] in Blood

55285

371310

3.93

307.65

21.0

18.7

259.68

254.42

e9/l

70.34

54385

361949

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11745

47259

1.96

307.65

2.5

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

9395

41073

1.75

307.65

2.2

2.5

102.49

137.51

ug/g

21.48

7384

32609

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

48576

308185

1.85

307.65

4.4

4.2

5.77

5.86

mmol/l

41.07

45350

283991

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7019

26888

1.97

307.65

2.2

1.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

10727

41164

2.05

307.65

2.0

1.7

1.45

1.41

6.58

9628

36653

(3023103) Potassium [Moles/volume] in Serum or Plasma

51608

329525

2.31

307.65

15.3

14.5

3.94

3.95

mmol/l

44.80

50549

320291

(3028300) Cannabinoids [Presence] in Urine

4836

15626

2.31

307.65

2.6

2.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

22287

119077

1.54

307.65

2.0

1.9

98.33

96.68

pmol/l

5.34

11683

62392

(3021960) Folate [Moles/volume] in Serum or Plasma

13241

64984

1.58

307.65

1.6

1.5

20.85

20.35

nmol/l

2.98

11709

55962

(3001604) Monocytes [#/volume] in Blood

27940

159828

1.47

307.65

5.6

6.0

0.56

0.57

e9/l

21.16

24378

139517

(3021601) Nitrite [Presence] in Urine by Test strip

27268

157361

1.44

307.65

4.8

4.7

0.00

estimate

0.42

5636

29704

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

24234

129009

1.58

307.65

2.4

2.3

3752.08

76.26

nmol/l

0.50

22301

117255

(3007164) IgA [Mass/volume] in Serum or Plasma

13507

64258

1.64

307.65

1.4

2.23

2.35

g/l

10.66

8239

39768

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

14574

74360

1.53

307.65

2.3

2.2

2.74

2.91

mg/l

15.46

12491

63814

(3013707) Erythrocyte sedimentation rate by Westergren method

40653

235076

1.81

307.65

4.0

3.9

10.06

11.44

mm/h

93.91

38102

218455

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

45149

250043

2.41

307.65

4.5

3.9

14.47

14.71

pmol/l

85.31

42219

228410

(3011288) Drugs identified in Urine by Screen method

3715

9961

2.76

307.65

3.5

2.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

22739

129563

1.41

303.58

4.2

4.9

36.56

35.83

g/l

76.77

21117

120552

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

11116

55375

1.53

297.40

1.3

31.87

33.90

iu/ml

0.16

3331

17911

(3021589) Normoblasts [#/volume] in Blood

24499

142070

1.39

290.75

8.9

9.3

0.00

e9/l

4.89

20021

116960

(3022096) Basophils/100 leukocytes in Blood

25035

145734

1.39

290.26

5.7

6.3

0.69

0.68

1.24

23405

136343

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

10484

52119

1.52

280.99

1.3

7.75

11.88

u/ml

8.79

4231

20452

(3018418) pH of Serum or Plasma

16121

87349

1.43

279.17

3.7

4.1

7.40

1.52

3032

16655

(3001019) Free T4 and TSH panel - Serum or Plasma

4529

18182

1.83

276.60

1.7

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

47007

306613

1.52

274.76

3.8

3.7

1.31

1.29

mmol/l

5.09

43949

284477

(3023511) Choriogonadotropin [Units/volume] in Urine

2347

7530

2.26

264.30

1.4

1.3

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

3517

13186

1.95

264.02

1.6

317.29

310.55

mu/l

0.34

3116

11940

(3018095) Leukocytes [#/volume] in Urine

19189

108383

1.39

256.22

3.8

3.6

74.06

90.92

e6/l

2.10

13239

74968

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

7936

37948

1.56

250.26

1.5

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10276

52109

1.49

246.02

2.6

3.0

2.43

2.45

mmol/l

39.10

8948

45604

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16009

88947

1.39

229.70

2.2

2.1

214.78

205.87

u/l

0.33

15096

83548

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

19294

110492

1.36

229.28

3.5

3.3

70.26

56.05

ng/l

0.29

10725

70257

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

11085

57737

1.45

229.15

1.5

—

(36304419) Bacteria [Presence] in Urine

14881

81716

1.40

228.81

3.1

3.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

861

1736

3.55

227.44

2.2

1.8

—

(40768797) Stomach Pathology biopsy report

8379

41377

1.51

225.83

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2757

10075

1.99

221.60

1.9

1.7

—

(3003338) MCHC [Mass/volume]

44279

288734

1.41

217.18

18.0

16.1

333.10

332.77

g/l

11.67

44019

286569

(3017143) Hepatitis C virus Ab [Presence] in Serum

8426

42083

1.49

213.82

1.7

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11507

61292

1.42

207.33

1.7

1.6

31461003.96

38310623.35

pmol/l

0.56

9825

51130

(3019832) Treponema pallidum Ab [Presence] in Serum

8182

40856

1.49

207.15

1.8

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4183

17804

1.72

206.89

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

20869

122337

1.33

205.76

3.7

3.6

—

(40758558) Short blood count panel - Blood

14315

79365

1.37

202.62

6.0

7.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

13247

72549

1.38

202.00

3.6

3.5

—

(36660697) Celiac disease serology panel - Serum

5717

26599

1.58

199.30

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1833

5973

2.21

198.11

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

9793

51178

1.43

194.41

1.8

1.7

1215.82

1159.58

nmol/l

6.91

7540

38908

(3030467) Casts [#/volume] in Urine by Automated count

14870

83392

1.36

194.06

3.1

0.30

0.41

e6/l

9.63

11099

62849

(3002582) Erythrocytes [#/volume] in Urine

16067

91221

1.35

193.37

3.2

3.1

68.07

83.95

e6/l

0.76

12107

69367

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

11134

59650

1.40

191.77

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

8702

44615

1.45

191.02

1.4

493.73

553.78

titre

2.06

1561

9072

(3029937) Albumin [Presence] in Urine by Test strip

14923

83973

1.35

189.60

4.0

3.9

0.00

estimate

0.13

5513

28648

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5965

28351

1.55

188.81

2.7

2.5

35.12

45.92

u/l

2.52

5117

24306

(3009214) Lutropin [Units/volume] in Serum or Plasma

2718

10511

1.88

184.20

1.5

1.4

8.68

9.86

u/l

5.30

2193

8623

(3036180) Methadone [Presence] in Urine

753

1610

3.35

182.23

3.3

2.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5095

23547

1.59

181.71

1.2

121.61

147.66

iu/ml

5.23

1914

8934

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4529

20545

1.61

174.14

3.2

3.4

4.51

4.53

pmol/l

0.67

4015

18407

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4916

22831

1.58

171.15

2.5

2.2

12.60

12.38

nmol/l

0.99

4440

20774

(3019150) Specific gravity of Urine by Refractometry

12360

68536

1.36

169.00

4.0

3.8

1.02

kg/l

0.81

1606

10592

(3033658) Prothrombin time (PT) actual/Normal

13857

78365

1.34

165.68

3.9

93.41

91.74

12.58

13430

76390

(40768804) Tissue Pathology biopsy report

21404

128787

1.29

161.44

2.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

761

1809

3.01

155.26

12.2

11.9

0.60

0.63

mmol/l

3.01

713

1656

(3025941) Bacteria identified in Stool by Culture

4131

18876

1.59

153.24

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

15121

87392

1.31

152.46

3.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2737

11235

1.76

152.19

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

11331

62941

1.35

150.23

2.5

2.6

6.70

5.96

e6/l

4.06

10089

56304

(3022948) Iron [Moles/volume] in Serum or Plasma

8771

46928

1.38

147.03

2.3

2.5

14.11

13.79

umol/l

0.34

8205

43792

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1430

4833

2.13

140.77

1.6

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2386

9641

1.79

139.68

1.9

1.7

39.77

40.38

nmol/l

0.52

2345

9429

(3020961) Endomysium IgA Ab [Titer] in Serum

3577

16151

1.61

138.87

1.1

110.23

210.44

titre

1.75

448

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6790

35117

1.42

137.72

2.4

2.8

6.74

8.30

umol/l

8.85

5665

30449

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1777

6563

1.95

137.50

2.0

1.8

193.97

196.72

pmol/l

0.46

1685

6271

(3013139) Helicobacter pylori Ag [Presence] in Stool

4424

21064

1.53

136.31

1.2

—

(3026008) Bacteria identified in Urine by Culture

15718

92621

1.28

132.44

3.0

2.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9292

50999

1.35

130.82

2.8

2.7

1.05

1.18

e6/l

1.14

4981

28683

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1507

5389

2.01

127.66

1.5

1.4

0.35

0.42

nmol/l

2.26

1206

4240

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8014

43129

1.37

127.61

2.3

2.5

2.43

2.36

g/l

20.38

7376

39903

(3004716) Salmonella sp identified in Stool by Organism specific culture

3812

18026

1.54

120.56

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

4360

21222

1.49

120.32

1.3

233.97

246.05

u/ml

0.17

4026

19640

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8656

47615

1.34

118.67

2.9

2.8

3.49

3.21

e6/l

1.10

4365

25459

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8687

47883

1.34

117.32

3.0

3.6

0.82

mmol/l

0.95

8060

44958

(3022145) Colonoscopy Study observation

6553

34581

1.39

116.70

1.3

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

9987

56231

1.31

116.14

3.8

3.5

248.54

510.58

ng/l

10.20

6702

41062

(3009466) Valproate [Moles/volume] in Serum or Plasma

1259

4389

2.06

114.21

5.6

5.1

369.44

372.10

umol/l

0.25

1113

3813

(3014765) Yersinia sp identified in Stool by Organism specific culture

2184

9195

1.71

110.41

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2166

9105

1.71

110.11

1.2

—

(3000492) Spirometry study

6219

32829

1.39

110.03

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

2187

9224

1.71

109.84

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2667

11877

1.62

108.77

1.4

1.3

227.70

223.92

miu/ml

0.20

1245

5580

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

529

1261

2.99

107.52

2.5

2.0

174.00

123.03

umol/l

2.00

272

650

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1211

4267

2.03

106.73

1.6

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1420

5294

1.92

106.69

1.4

1.3

22.56

25.91

u/l

3.39

1160

4392

(3026782) Osmolality of Urine

10432

59808

1.29

104.42

2.7

2.8

527.69

541.74

mosm/kgh2o

7.14

8805

51411

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2617

11838

1.59

99.91

1.7

—

(3008898) HLA-B27 [Presence]

2629

11917

1.59

99.49

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7305

40207

1.33

97.76

2.4

2.6

23.27

22.90

1.38

6351

34346

(3042517) Benzodiazepines panel - Urine

240

344

4.96

97.59

3.0

3.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5168

27044

1.39

95.42

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6962

38192

1.33

95.08

5.1

6.2

1.05

mmol/l

0.05

6461

35724

(3007853) Bacteria identified in Skin by Aerobe culture

6738

36914

1.33

92.66

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2708

12597

1.55

91.46

1.6

3.39

3.92

mg/l

3.04

2097

8883

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2849

13432

1.53

90.54

1.1

17.03

6.84

u/ml

0.46

205

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1947

8435

1.66

88.21

1.4

298.87

274.19

ug/g

3.81

1065

4856

(3026493) Urate [Moles/volume] in Serum or Plasma

13277

79991

1.23

83.68

2.3

2.6

2103.44

4115.44

umol/l

13.43

11818

70829

(3020191) Ethanol [Moles/volume] in Serum or Plasma

782

2558

2.18

83.50

1.6

1.4

1.50

1.38

promille

1.22

570

2003

(3022217) INR in Platelet poor plasma by Coagulation assay

21534

136133

1.20

82.28

12.1

13.1

1.16

1.23

inr

18.85

6930

40250

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

23657

151060

1.19

79.95

2.4

2.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4227

22029

1.39

79.22

2.4

2.3

22.09

22.51

au/ml

0.10

361

1792

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2468

11610

1.53

79.01

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2665

12755

1.50

78.67

1.2

0.72

0.88

u/ml

0.32

265

1070

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3907

20142

1.40

77.99

1.3

44.94

51.84

au/ml

1.02

170

983

(3000494) Fungus identified in Specimen by Culture

6486

36176

1.31

77.37

1.4

1.5

—

(1761868) Lipid panel - Serum or Plasma

19348

121672

1.19

76.63

2.5

2.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

13314

80886

1.22

75.89

1.6

1.43

1.38

mmol/l

6.62

11596

68502

(3009508) Creatinine [Moles/volume] in Urine

15255

93956

1.21

75.46

3.2

7.85

7.89

mmol/l

0.11

13266

80089

(3014111) Lactate [Moles/volume] in Serum or Plasma

4705

25173

1.35

74.66

6.5

7.3

1.36

1.34

mmol/l

0.45

4590

24563

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5124

27809

1.34

73.93

2.3

0.23

0.22

g/l

18.66

4739

25946

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2058

9562

1.55

69.57

1.4

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5714

31795

1.30

68.76

1.8

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2074

9680

1.54

68.69

1.1

5.34

5.46

u/ml

0.03

293

1289

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1862

8507

1.57

67.77

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2408

11688

1.48

66.17

1.5

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5668

31659

1.30

66.13

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2821

14122

1.44

66.04

4.5

24.16

24.11

mmol/l

0.41

2743

13844

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8032

46933

1.25

64.66

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1901

8834

1.54

64.16

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2323

11387

1.47

60.65

1.4

—

(40761536) Microorganisms panel - Urine sediment

4933

27349

1.31

60.52

3.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1616

7358

1.57

59.64

1.1

1.89

2.29

u/ml

1.01

811

3765

(3044640) Blood type and Crossmatch panel - Blood

15839

99483

1.18

59.44

2.2

2.3

—

(21494755) Public health laboratory ask at order entry panel

6612

38317

1.25

56.56

1.3

—

(4200892) Spirometry reversibility

4044

22028

1.32

56.13

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1524

6959

1.57

55.55

1.4

1.5

1060.06

2325.19

e6/l

0.98

1230

5651

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3970

21604

1.33

55.45

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2380

11934

1.43

55.05

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1686

7891

1.53

55.04

1.4

468.23

538.37

mg/l

3.87

1605

7523

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1520

6956

1.56

54.87

1.4

33.66

29.84

e6/l

0.14

1154

5382

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1384

6211

1.59

54.31

1.1

1.94

2.15

u/ml

0.33

677

3162

(3003888) Timothy IgE Ab [Units/volume] in Serum

1458

6631

1.57

54.07

1.1

5.47

5.90

u/ml

0.42

764

3494

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1207

5252

1.64

53.67

1.1

12.85

12.04

au/ml

0.13

334

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1208

5272

1.64

53.09

1.1

4.21

4.45

u/ml

0.18

561

2596

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1140

4928

1.65

52.01

1.1

5.13

5.34

u/ml

0.13

485

2121

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6544

38265

1.24

51.23

1.7

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1500

6951

1.54

51.23

1.3

3.69

3.72

mmol/l

0.49

1411

6518

(40761535) Cells panel - Urine sediment

4281

23866

1.29

49.91

3.5

3.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1377

6306

1.56

49.56

1.1

0.81

1.22

u/ml

2.41

564

2769

(3000991) Gas panel - Venous blood

4365

24487

1.29

48.42

8.0

8.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1133

5035

1.61

46.33

1.1

2.90

2.91

u/ml

0.02

569

2463

(3003740) Influenza virus B Ag [Presence] in Specimen

1255

5720

1.57

46.13

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1055

4621

1.63

45.74

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1613

7779

1.48

45.63

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6168

36261

1.23

45.51

6.4

6.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1251

5723

1.56

45.25

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

544

1964

1.97

45.03

1.6

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

1398

6573

1.52

44.69

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

975

4239

1.64

43.55

1.1

1.0

0.67

0.41

u/ml

0.71

249

1137

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

686

2705

1.81

43.46

1.9

2.2

20.47

19.47

nmol/l

1.56

645

2574

(3042936) Bacteria identified in Isolate by Culture

7175

43013

1.21

43.42

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3025

16441

1.32

42.29

1.7

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3151

17263

1.31

41.59

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

353

1114

2.25

41.37

2.3

2.4

138.04

155.63

nmol/l

2.48

320

950

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

11989

75375

1.16

41.23

2.2

2.3

—

(3023368) Bacteria identified in Blood by Culture

12459

78624

1.16

40.66

4.3

4.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

4215

24158

1.26

38.83

2.3

2.7

10.41

10.56

g/l

1.48

3795

22187

(3045414) Leukocytes [Presence] in Urine

2592

13955

1.33

38.65

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1034

4713

1.57

38.05

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4621

26845

1.24

37.69

4.1

5.89

5.83

kpa

3.89

4465

26082

(3024354) Oxygen [Partial pressure] in Venous blood

3855

21964

1.26

37.31

3.5

3.4

4.73

4.66

kpa

1.23

3703

21274

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2762

15136

1.31

36.29

2.3

2.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

7442

45434

1.19

36.26

2.1

2.2

29.60

29.74

1.23

7216

44087

(3027945) Reticulocytes/100 erythrocytes in Blood

5294

31355

1.22

35.76

2.4

2.6

1.77

1.76

0.50

4632

27926

(3002032) Base excess in Venous blood by calculation

4589

26786

1.23

35.73

4.1

1.75

1.85

mmol/l

1.11

3925

22834

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1047

4868

1.53

35.30

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1169

5569

1.50

35.17

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

549

2172

1.80

34.52

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3303

18661

1.27

34.22

1.7

1.9

1.32

1.30

g/l

0.16

3013

17074

(3002256) Pathology report gross observation

6648

40377

1.19

34.21

1.3

—

(3012544) pH of Venous blood

4725

27790

1.22

34.13

4.0

4.1

7.37

7.38

0.31

210

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

545

2161

1.80

34.03

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

4182

24292

1.24

34.00

2.6

71.73

67.66

ml/min/173m2

8.28

1719

9317

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1140

5454

1.49

33.61

1.1

—

(3017732) Neutrophils [#/volume] in Blood

3896

22486

1.25

33.57

2.4

2.8

4.59

4.87

e9/l

0.73

3215

18433

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1262

6163

1.46

33.56

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1157

5554

1.49

33.55

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1261

6161

1.46

33.46

1.3

—

(44813793) Dust mix specific IgE antibody measurement

591

2417

1.74

33.24

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1041

4906

1.51

33.00

1.3

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2460

13450

1.31

32.84

2.0

1.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

769

3390

1.62

32.63

1.2

47.50

26.50

nmol/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1138

5477

1.48

32.59

1.3

3.46

3.70

ug/l

0.46

1048

4911

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

501

1964

1.82

32.50

1.3

5.07

5.21

umol/l

0.35

458

1817

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4126

24046

1.23

32.48

3.4

3.8

1.23

mmol/l

1.46

3603

21023

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

468

1806

1.84

31.94

1.4

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3682

21243

1.24

31.78

1.4

1.5

—

(3023410) Appearance of Cerebral spinal fluid

728

3195

1.62

31.47

1.6

—

(4034850) Laboratory test

1855

9796

1.35

31.43

9.4

9.1

—

(3008295) Osmolality of Serum or Plasma

653

2801

1.66

30.89

1.8

1.5

280.56

280.10

mosm/kgh2o

0.19

481

2227

(3023183) Ammonium ion [Moles/volume] in Plasma

1221

6029

1.45

30.68

2.6

2.9

33.00

34.17

umol/l

0.90

1097

5477

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1581

8176

1.38

30.56

1.9

3.80

21.37

iu/l

1.66

587

3057

(3024928) Oxygen saturation in Venous blood

1208

5986

1.44

29.80

3.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1345

6806

1.41

29.55

1.2

36.39

44.06

u/ml

0.82

117

682

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

543

2244

1.72

29.50

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

1730

9136

1.35

29.32

2.8

3.1

—

(3025130) Human papilloma virus identified in Specimen

1034

4988

1.48

29.32

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

405

1535

1.88

29.28

1.8

1.5

2008232.43

1785162.06

iu/ml

0.14

109

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1885

10093

1.34

29.15

1.7

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1718

9087

1.35

28.82

1.2

1.3

24.37

37.21

u/ml

1.39

556

(3007566) Smooth muscle Ab [Titer] in Serum

1722

9122

1.35

28.60

1.2

1.3

101.21

122.35

titre

0.67

157

847

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1890

10197

1.32

27.74

1.7

1.18

g/l

0.05

1808

9698

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3185

18352

1.24

27.73

6.9

7.5

24.86

24.77

mmol/l

0.72

3155

18188

(3016018) Differential panel - Cerebral spinal fluid

756

3453

1.56

27.71

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1075

5288

1.45

27.60

1.9

2.2

5.81

6.84

umol/l

1.12

792

3862

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

154

399

2.74

27.44

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

1522

7999

1.36

26.63

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1833

9905

1.32

26.61

1.7

0.23

g/l

0.37

1749

9388

(3003694) ABO and Rh group [Type] in Blood

14810

96655

1.12

26.31

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11986

77328

1.13

25.95

2.8

2.9

1122.40

1267.31

ng/l

2.77

9840

65460

(3017315) Amylase [Enzymatic activity/volume] in Urine

409

1619

1.80

25.84

1.4

1.2

260.02

332.16

u/l

0.90

380

1518

(3007463) Buprenorphine [Presence] in Urine

126

4.22

25.72

9.3

7.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

125

301

2.95

25.42

1.3

1.2

2.16

2.38

mmol/l

—

(3034770) Mitochondria Ab [Titer] in Serum

1673

8982

1.33

25.42

1.2

1.3

816.19

960.71

titre

0.39

255

(3016244) Insulin [Units/volume] in Serum or Plasma

529

2269

1.66

25.15

2.9

3.3

29.60

27.34

mu/l

0.56

491

2134

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4914

29825

1.18

25.01

3.3

3.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

351

1347

1.85

24.53

1.6

2.0

1.95

umol/l

0.02

322

1269

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1007

5026

1.43

23.98

2.4

2.5

13.08

13.15

1.28

996

4961

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3912

23352

1.20

23.97

2.5

2.2

5.92

7.43

ug/l

5.07

3364

20379

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3693

21946

1.21

23.73

3.6

4.0

83.21

89.50

ng/l

3.73

3212

19101

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

885

4348

1.45

22.96

1.2

1.3

0.58

1.29

nmol/l

1.24

852

4189

(3010421) pH of Blood

1463

7824

1.33

22.86

3.5

3.8

7.42

0.49

1320

7148

(1761482) Bacteria [#/volume] in Urine by Culture

717

7467

0.68

22.70

3.9

4.0

—

(3013512) EKG study

12930

84322

1.11

22.59

3.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

817

3970

1.47

22.45

1.5

—

(3003181) Sodium [Moles/volume] in Urine

944

4719

1.43

22.32

1.5

1.4

61.77

63.75

mmol/l

0.72

729

3730

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

298

1120

1.89

22.26

1.3

1.4

13.97

14.98

pmol/l

2.51

256

940

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1552

8407

1.32

22.19

1.3

7.65

9.41

u/ml

0.55

232

1303

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1280

6740

1.35

22.19

1.3

1.4

—

(3017509) Phencyclidine [Presence] in Urine

147

417

2.50

22.06

2.4

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

876

4334

1.44

21.92

1.3

0.22

0.25

nmol/l

0.24

258

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1529

8282

1.32

21.88

1.3

4.74

7.40

u/ml

1.11

143

864

(3020891) Body temperature

1984

11123

1.27

21.84

4.9

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

334

1312

1.81

21.74

1.4

73.30

72.87

0.20

315

1249

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

294

1110

1.88

21.68

2.1

2.5

1.13

1.16

ug/l

0.08

277

1039

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3810

22899

1.19

21.60

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

5238

32329

1.16

21.53

6.9

7.5

12.36

12.71

kpa

4.77

5014

30839

(3024980) IgG subclass 4 [Mass/volume] in Serum

1029

5257

1.39

21.51

1.5

1.6

0.72

0.75

g/l

0.48

773

3981

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5239

32348

1.16

21.41

6.9

7.5

5.11

5.08

kpa

1.12

5018

30870

(1616796) Gas panel - Central venous blood

1256

6636

1.35

21.31

3.1

3.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

3018

17774

1.22

21.25

8.7

9.7

93.71

94.02

1.86

3003

17713

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3007

17708

1.22

21.19

8.6

9.5

1.49

1.37

6.68

2998

17593

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3130

18508

1.21

21.15

3.4

3.6

5.14

kpa

0.07

2980

17514

(3009343) pH of Capillary blood

3093

18271

1.21

21.12

3.4

3.6

7.42

0.04

414

2364

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

312

1214

1.83

20.97

1.2

—

(3003396) Base excess in Arterial blood by calculation

5234

32370

1.16

20.92

6.9

7.5

0.97

1.04

mmol/l

0.53

4239

25758

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2996

17673

1.21

20.75

3.4

3.6

1.54

1.66

mmol/l

1.14

2171

12963

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3000

17699

1.21

20.75

8.7

9.6

0.68

0.04

2991

17597

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1800

10043

1.28

20.61

2.1

2.4

429.31

519.17

ug/l

0.76

1640

9360

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

325

1289

1.79

20.53

1.4

567.31

676.10

mu/l

0.50

306

1226

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

175

557

2.23

20.43

1.6

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

694

3329

1.48

20.41

1.3

1.4

3.02

2.94

g/l

0.55

482

2320

(4062490) Immunoglobulin typing, IgG

695

3335

1.48

20.40

1.3

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2543

14799

1.23

20.14

8.8

9.9

24.42

24.29

mmol/l

1.17

2443

14346

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

412

1761

1.66

19.98

1.1

4.18

5.02

nmol/l

0.14

340

(3024139) IgG subclass 3 [Mass/volume] in Serum

691

3330

1.48

19.87

1.3

1.4

0.37

0.41

g/l

1.29

483

2327

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

791

3917

1.44

19.76

1.2

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

691

3335

1.47

19.73

1.3

1.4

6.55

6.78

g/l

0.81

483

2322

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

475

2129

1.59

19.08

1.1

6.85

8.45

iu/ml

0.65

120

552

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

272

1049

1.84

18.87

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

5431

33967

1.15

18.49

1.7

—

(3012501) Base excess in Blood by calculation

1257

6804

1.32

18.14

3.7

3.9

2.37

2.49

mmol/l

0.86

826

4571

(3013290) Carbon dioxide [Partial pressure] in Blood

1257

6806

1.32

18.11

3.7

3.9

5.01

5.00

kpa

0.18

1228

6646

(3015076) Soybean IgE Ab [Units/volume] in Serum

451

2025

1.58

18.01

1.0

0.54

0.92

u/ml

0.58

101

543

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

497

2283

1.55

17.98

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

696

3428

1.44

17.95

1.1

94.50

66.96

au/ml

—

(3016502) Oxygen saturation in Arterial blood

4656

28866

1.16

17.90

7.2

8.0

95.73

95.81

0.40

4522

27735

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

638

3093

1.47

17.87

1.0

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

3789

23132

1.17

17.80

2.4

2.7

71.09

70.14

e9/l

0.77

2710

17432

(3014599) Egg white IgE Ab [Units/volume] in Serum

488

2238

1.55

17.79

1.0

1.1

8.21

2.53

u/ml

0.44

120

598

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.42

17.73

1.7

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

405

1782

1.62

17.61

1.4

1.5

6.00

8.53

ug/l

4.63

374

1608

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

144

451

2.27

17.54

1.0

84.62

80.82

ug/l

0.46

121

368

(3050129) First trimester maternal screen panel - Serum or Plasma

2422

14228

1.22

17.50

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

1259

6853

1.31

17.47

3.7

3.9

8.88

8.73

kpa

2.29

1230

6692

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

248

953

1.85

17.45

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1256

6836

1.31

17.44

1.3

243.76

262.94

u/ml

1.83

802

4419

(3041806) Other cells [#/volume] in Blood by Manual count

377

1634

1.64

17.41

1.6

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2259

13190

1.22

17.35

3.3

3.0

1.46

1.28

8.10

2249

13124

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1325

7270

1.30

17.34

1.2

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

348

1482

1.67

17.20

1.5

1.6

17.84

5.30

nmol/l

0.39

289

1231

(3018405) Lactate [Moles/volume] in Arterial blood

1712

9714

1.26

17.11

4.1

4.2

1.37

mmol/l

0.04

1691

9544

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

195

696

1.99

17.07

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

461

2113

1.55

16.88

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1850

10624

1.24

16.63

1.5

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10587

81151

0.91

16.61

4.5

4.4

2.24

2.85

ug/l

2.44

9606

73486

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2292

13474

1.21

16.45

2.0

40.20

39.52

u/l

0.89

2065

12100

(3038515) Glucose [Moles/volume] in Venous blood

575

5864

0.69

16.39

3.1

3.2

6.99

7.50

mmol/l

4.46

555

5766

(3025159) Blasts/100 leukocytes in Blood

3892

23979

1.16

16.24

3.9

4.3

0.15

0.31

1.11

880

6413

(3020874) Milk IgE Ab [Units/volume] in Serum

492

2311

1.51

16.14

1.0

1.1

3.94

1.74

u/ml

0.57

158

790

(3020717) Zinc [Moles/volume] in Serum or Plasma

367

1615

1.61

16.00

1.5

24.55

24.77

umol/l

0.05

347

1541

(43055514) Macroprolactin [Presence] in Serum or Plasma

246

972

1.80

15.88

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2200

12928

1.21

15.87

3.3

3.0

0.64

0.66

1.94

2194

12879

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2909

17549

1.18

15.77

2.3

3.3

34.82

52.43

u/ml

2.88

2814

16944

(3036489) Thrombin time

2108

12345

1.22

15.74

2.0

2.2

20.89

21.48

5.18

1792

10676

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

201

747

1.91

15.72

1.4

1.3

118.14

135.14

nmol/l

0.49

153

550

(3019225) pH of Specimen

4607

28825

1.14

15.50

3.7

4.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

162

568

2.02

14.97

1.5

0.22

0.23

nmol/l

0.09

114

423

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1255

6982

1.28

14.82

1.9

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

301

3424

0.62

14.73

2.5

2.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

276

1156

1.70

14.61

1.1

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

952

5115

1.32

14.58

2.3

2.1

3.79

7.71

titre

1.34

150

(3002179) Metamyelocytes/100 leukocytes in Blood

3894

24183

1.15

14.56

3.6

4.0

0.67

0.02

1058

7638

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

812

4268

1.35

14.42

1.9

1.8

3360.00

4014.55

titre

0.16

187

(3015183) Erythrocyte sedimentation rate

384

1753

1.56

14.41

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1684

9729

1.23

14.37

1.7

1.8

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

262

2.52

14.35

1.2

44.88

48.03

mg/l

0.33

(3022806) Fractional oxyhemoglobin in Capillary blood

744

3863

1.37

14.29

1.9

1.8

90.17

90.11

0.11

733

3799

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

597

2986

1.42

14.28

1.4

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4289

26852

1.14

14.27

7.5

8.3

123.44

121.69

g/l

6.48

4205

26078

(3001556) Androgen free Index in Serum or Plasma

122

390

2.22

14.27

1.3

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1906

11173

1.22

14.12

1.4

—

(3045424) Erythrocytes [Presence] in Urine

989

5370

1.31

14.08

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

534

2624

1.45

14.07

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

538

2650

1.44

14.00

1.5

1.3

183.71

186.97

pmol/l

0.06

538

2650

(3006922) Hepatitis E virus Ab [Presence] in Serum

490

2371

1.47

13.99

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1896

11121

1.22

13.97

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

559

2775

1.43

13.95

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1905

11181

1.21

13.94

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1375

7795

1.26

13.92

2.0

2.2

0.04

0.03

g/l

0.25

1240

7148

(3005082) Progesterone [Moles/volume] in Serum or Plasma

450

2145

1.49

13.85

1.3

1.4

32.69

31.51

nmol/l

0.35

404

1978

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1899

11155

1.21

13.79

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2018

11926

1.21

13.76

1.4

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

563

2810

1.42

13.66

1.2

36.58

43.75

mg/l

2.20

455

2363

(3043409) Potassium [Moles/volume] in Arterial blood

1466

8396

1.24

13.58

4.3

4.5

3.83

3.87

mmol/l

2.45

1460

8325

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

236

968

1.73

13.51

1.1

1.3

17.41

21.17

0.28

174

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

454

2183

1.48

13.41

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

452

2174

1.48

13.33

1.0

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

680

3521

1.37

13.33

1.1

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

4027

25235

1.14

13.20

3.8

4.3

0.14

0.11

0.70

1014

7586

(3002079) Sodium [Moles/time] in 24 hour Urine

328

1478

1.58

13.08

1.3

1.2

151.80

159.74

mmol/24h

1.03

328

1478

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1271

7197

1.26

13.03

2.0

2.3

0.00

g/l

0.21

1143

6568

(3017181) Myelocytes/100 leukocytes in Blood

4210

26498

1.14

12.91

3.8

4.2

0.98

0.94

0.35

1192

8815

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

148

532

1.97

12.85

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1359

7768

1.25

12.84

1.4

83.76

133.59

pmol/l

5.75

1319

7577

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

257

1096

1.67

12.80

1.2

109.37

111.34

0.55

230

980

(3028626) Oxygen [Partial pressure] in Capillary blood

1250

7082

1.26

12.76

3.5

8.63

8.48

kpa

2.22

1221

6904

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1253

7101

1.26

12.76

2.0

2.3

0.00

g/l

-0.00

1141

6547

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1587

9233

1.22

12.71

1.4

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

291

1284

1.61

12.68

1.6

2.0

29.14

28.70

umol/l

0.32

273

1245

(3028271) Lactate [Moles/volume] in Capillary blood

875

4742

1.31

12.68

2.0

1.8

1.77

1.74

mmol/l

0.34

852

4630

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1190

6709

1.26

12.67

1.2

22.32

13.73

u/ml

0.23

104

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

138

487

2.01

12.62

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

798

4272

1.33

12.61

1.5

1.6

67.65

64.46

mu/l

0.16

716

3829

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

368

1718

1.52

12.56

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1205

6815

1.26

12.50

1.2

4.97

5.57

u/ml

0.08

518

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

450

2192

1.46

12.48

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

539

2721

1.41

12.33

1.1

240.79

265.41

mg/l

1.14

469

2396

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1019

5659

1.28

12.29

2.6

3.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

348

1614

1.53

12.26

1.2

1.3

62.20

64.65

0.14

203

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

159

597

1.89

12.19

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

357

1670

1.52

12.10

1.0

258.72

344.20

ng/l

3.21

260

1196

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1406

8123

1.23

12.07

1.4

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1949

11633

1.19

11.99

3.7

3.9

24.65

24.80

mmol/l

1.67

1847

10789

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1391

8036

1.23

11.95

1.9

2.2

38.56

37.88

g/l

3.95

1207

7004

(3005033) Fetal Nuchal fold Thickness US

1544

9024

1.22

11.85

1.4

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

658

6218

0.75

11.82

2.9

3.1

1.55

mmol/l

0.03

633

6098

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1545

9041

1.22

11.72

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

1642

9667

1.21

11.71

2.4

2.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

357

1684

1.51

11.65

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

349

1641

1.51

11.57

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

379

1817

1.48

11.45

1.4

1.5

6.21

5.74

u/l

0.42

322

1528

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

356

1686

1.50

11.41

1.0

33.19

43.15

ng/l

4.96

255

1182

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

4.09

11.38

1.8

1.4

215.59

333.13

nmol/l

0.55

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

733

3938

1.32

11.36

1.3

1.4

347.17

384.51

pmol/l

0.45

650

3444

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1502

8798

1.22

11.30

2.1

2.4

0.70

0.80

g/l

0.53

1294

7581

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

268

1194

1.59

11.29

1.2

0.30

0.31

g/l

0.86

213

950

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

354

1684

1.49

11.13

1.0

817.92

739.22

ng/l

2.28

242

1166

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

481

2429

1.41

11.04

1.2

1.3

2.70

1.96

u/ml

0.54

260

1367

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1467

8597

1.22

11.00

1.9

2.1

10.49

10.81

mg/l

0.87

1358

8048

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

676

3609

1.33

10.97

2.0

26.93

25.37

mg/l

0.29

197

959

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8452

64313

0.92

10.63

4.0

3.9

21.64

21.91

0.73

3393

28505

(40767503) Oxygen content in Capillary blood by calculation

1111

6351

1.24

10.57

2.5

16.91

16.56

1.74

547

3259

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1626

9662

1.20

10.55

2.4

2.7

174.80

185.14

5.19

1528

9159

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

446

2244

1.41

10.49

13.6

13.3

789.53

1513.95

nmol/l

0.82

433

2168

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1198

6914

1.23

10.45

2.1

2.2

132.93

130.70

g/l

2.35

864

5103

(3028717) Thiamine [Mass/volume] in Blood

295

2.19

10.44

1.2

—

(3016038) Potassium [Moles/volume] in Urine

372

1813

1.46

10.40

1.3

31.29

34.51

mmol/l

1.95

313

1571

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1644

9795

1.20

10.37

2.0

2.3

2.86

2.93

g/l

2.31

1462

8782

(40768443) Skin Pathology biopsy report

2227

13614

1.17

10.34

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

1363

7981

1.22

10.33

2.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

109

381

2.03

10.33

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

259

1173

1.57

10.24

1.2

113.59

108.02

1.29

228

1065

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

465

2367

1.40

10.24

18.2

18.8

1346.06

2778.98

nmol/l

1.09

450

2272

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

112

397

2.00

10.22

1.1

1.0

—

(3022313) Gas panel - Capillary blood

2159

13188

1.17

10.13

3.6

3.8

—

(3022621) pH of Urine by Test strip

3247

20440

1.13

9.94

2.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3757

29633

0.89

9.81

3.2

4.1

12.43

24.63

ug/l

3.18

2850

23636

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

959

5443

1.25

9.77

1.3

1.2

3.96

3.68

u/ml

0.18

327

1874

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

895

5047

1.26

9.64

1.1

119.56

118.32

0.57

810

4578

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

482

2495

1.37

9.63

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

929

5266

1.25

9.58

1.3

1.2

3.84

3.89

u/ml

0.04

404

2375

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

484

2512

1.37

9.52

1.2

1.3

1.91

2.08

mmol/l

2.25

448

2324

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1473

8764

1.20

9.47

1.8

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

925

5251

1.25

9.42

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

251

1152

1.55

9.41

1.1

94.07

91.06

0.71

106

546

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1250

7329

1.21

9.39

2.8

3.1

24.40

24.67

mmol/l

1.57

1217

7159

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

717

3949

1.29

9.36

1.3

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

387

1941

1.42

9.33

1.1

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

709

3910

1.29

9.18

1.3

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

571

3058

1.33

9.16

3.9

4.8

127.28

114.13

u/ml

0.14

153

1002

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

245

1126

1.54

9.15

1.1

99.15

91.40

1.83

105

539

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

708

3906

1.29

9.14

1.3

1.4

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

334

1638

1.45

9.11

1.8

1.9

127.56

141.53

3.42

314

1545

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

296

1420

1.48

9.04

1.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

639

5835

0.77

9.03

2.6

3.4

378.12

884.85

u/ml

1.77

569

5316

(3045716) Anion gap in Serum or Plasma

266

1249

1.51

9.01

2.0

2.5

9.66

9.84

mmol/l

0.35

259

1211

(3004588) Protein electrophoresis panel - Serum or Plasma

2926

18415

1.13

9.01

2.0

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

706

3904

1.29

8.96

1.3

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

118

447

1.87

8.96

1.8

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1742

10569

1.17

8.95

1.6

246.67

298.48

titre

0.37

425

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

728

4048

1.28

8.85

1.3

1.4

—

(3019060) Gas panel - Arterial blood

2926

18445

1.13

8.79

4.4

4.9

—

(3004616) Nuclear Ab [Presence] in Serum

705

3910

1.28

8.76

1.4

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2165

13382

1.15

8.73

1.4

1.6

10.68

14.47

u/ml

0.64

399

(3024522) Salmonella sp identified in Specimen by Organism specific culture

713

3962

1.28

8.72

1.3

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1371

8187

1.19

8.52

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2081

12853

1.15

8.49

1.7

1.8

1.46

1.51

g/l

1.78

1775

11004

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

143

586

1.73

8.43

1.4

1.5

5.19

5.69

nmol/l

0.94

133

563

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

162

2.45

8.37

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1734

10581

1.17

8.32

2.4

2.5

95.16

92.93

4.07

1645

10156

(3020779) Urea [Moles/volume] in Serum or Plasma

3986

25657

1.11

8.31

6.6

8.0

8.30

9.41

mmol/l

21.17

3806

24453

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

176

767

1.63

8.27

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

947

5486

1.23

8.09

1.7

1.6

—

(3021788) Differential panel - Synovial fluid

943

5462

1.23

8.07

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

417

2174

1.36

8.06

1.1

1.05

1.07

ratio

3.81

162

754

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

236

1111

1.51

7.96

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.13

7.93

1.1

—

mmol/l

—

(3010838) Calcium [Moles/time] in 24 hour Urine

974

5673

1.22

7.91

1.9

5.25

5.22

mmol/24h

0.10

857

5066

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5106

33365

1.09

7.80

3.4

4.3

227.57

243.26

u/l

15.48

4788

31640

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

232

1095

1.50

7.75

1.1

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

141

591

1.69

7.72

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

106

2.74

7.66

1.5

1.3

362.42

548.16

nmol/l

1.84

106

(3027231) Wheat IgE Ab [Units/volume] in Serum

169

748

1.60

7.51

1.0

1.1

4.65

2.43

u/ml

0.24

138

641

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

466

2502

1.32

7.45

1.1

296.88

407.64

mg/l

0.46

420

2249

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

250

2.07

7.44

1.0

0.29

1.23

u/ml

1.26

166

(3021901) Oxygen saturation in Capillary blood

908

5291

1.22

7.37

2.5

2.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1586

9708

1.16

7.36

2.0

2.2

9.88

10.17

g/l

2.05

1395

8644

(3051101) Glucose [Moles/volume] in Cord blood

488

0.32

7.32

5.0

5.5

—

(3044941) Cell count panel - Synovial fluid

800

4606

1.23

7.30

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

315

1597

1.40

7.27

1.1

13.03

9.53

u/ml

0.66

284

(3011841) English Walnut IgE Ab [Units/volume] in Serum

361

1.87

7.24

1.0

1.1

1.18

2.49

u/ml

0.58

278

(3004119) Hemoglobin [Mass/volume] in Venous blood

2716

17253

1.12

7.23

3.4

3.5

131.90

129.45

g/l

7.14

2655

16844

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

150

651

1.63

7.23

1.1

1.13

7.69

u/ml

3.07

478

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

372

1.85

7.19

1.0

0.27

0.19

u/ml

0.26

230

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2461

15548

1.13

7.19

2.5

2.7

0.28

e6/l

0.01

2366

15106

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

590

3287

1.28

7.17

1.2

64.09

65.02

u/l

0.10

522

2962

(3051651) Icteric interference index of Serum or Plasma

352

1825

1.37

7.11

3.3

3.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1688

10409

1.15

7.11

2.0

2.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

732

4187

1.24

7.11

1.2

54.56

50.80

u/ml

0.14

276

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1690

10423

1.15

7.10

2.0

2.2

7.22

7.38

g/l

3.76

1509

9406

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

292

1468

1.41

7.08

1.8

2.3

20.85

153.65

ug/l

1.90

276

1401

(3020630) Protein [Mass/volume] in Serum or Plasma

3539

22838

1.11

7.04

2.1

2.6

66.82

66.58

g/l

1.06

3196

20849

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1684

10392

1.15

7.02

2.0

2.2

3.69

3.70

g/l

0.14

1505

9383

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

1.96

2.89

mg/l

0.82

189

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

2.31

1.97

mg/l

0.19

169

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

1.71

2.60

mg/l

1.17

184

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

1.83

1.86

mg/l

0.02

192

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

0.75

0.96

mg/l

0.30

173

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

2.13

2.26

mg/l

0.08

195

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

2.29

1.78

mg/l

0.32

162

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

1.59

1.24

mg/l

0.26

161

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

271

1.99

6.98

1.6

4.41

3.72

mg/l

0.39

165

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

311

1.92

6.94

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

390

2064

1.34

6.92

1.8

2.3

98.54

97.67

0.20

351

1929

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

426

2288

1.32

6.84

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

231

1121

1.46

6.80

2.6

2.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

279

1.96

6.78

1.6

2.02

1.75

mg/l

0.17

174

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

824

4800

1.22

6.76

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

490

2689

1.29

6.74

1.4

1.3

1.50

1.42

nmol/l

0.89

455

2423

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

477

2610

1.30

6.71

3.6

4.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

408

2186

1.33

6.68

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

252

1249

1.43

6.65

2.2

2.0

—

(3004775) Volume in Urine collected for unspecified duration

234

2362

0.70

6.63

2.0

2.3

679.47

672.21

0.10

159

1654

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

209

2.10

6.63

1.1

1.3

6.07

4.23

u/ml

0.17

175

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

126

536

1.67

6.60

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

316

1639

1.37

6.43

1.3

98.93

71.50

titre

0.25

140

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

244

1212

1.43

6.38

1.8

2.0

142.88

165.60

4.11

221

1153

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

359

1902

1.34

6.37

1.1

1.08

1.06

u/l

0.14

147

867

(3010015) Selenium [Moles/volume] in Serum or Plasma

271

1.94

6.35

2.0

2.2

1.26

1.30

umol/l

0.64

245

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

323

1688

1.36

6.28

1.3

434.80

451.14

titre

0.03

105

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

318

1664

1.36

6.14

1.5

1.6

—

(3035933) Granulocytes/100 leukocytes in Blood

198

956

1.47

6.04

1.9

1.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1187

7225

1.17

6.01

1.4

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

300

1562

1.36

5.99

1.0

1.1

95.68

97.66

0.57

241

1251

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1103

6681

1.17

5.94

1.4

1.5

102.40

111.87

u/ml

2.84

277

1465

(40768800) Prostate Pathology biopsy report

508

4518

0.80

5.94

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

861

5106

1.20

5.93

1.1

1.2

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

376

1.75

5.90

1.0

0.12

3.18

u/ml

1.25

210

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

377

2039

1.31

5.85

2.5

3.3

74.84

130.64

nmol/l

7.58

368

2000

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

359

1929

1.32

5.83

1.6

1.5

28.46

23.10

u/ml

0.96

360

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

207

1017

1.44

5.79

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

368

1.75

5.77

1.0

0.09

0.82

u/ml

1.63

209

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

100

416

1.71

5.75

1.4

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1687

10571

1.14

5.70

1.6

8.77

5.68

iu/ml

0.15

348

2201

(3051611) Lipemic interference index of Serum or Plasma

553

3150

1.25

5.68

3.0

3.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

202

992

1.44

5.68

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

340

1.77

5.61

1.0

0.33

0.51

u/ml

0.35

199

(40757494) Bilirubin.total [Moles/volume] in Blood

289

1515

1.35

5.57

2.0

2.2

20.43

35.59

umol/l

1.59

152

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

254

1.90

5.56

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

313

1664

1.34

5.50

1.2

2.82

14.83

u/ml

2.59

168

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1594

9977

1.14

5.50

2.7

2.8

3.60

3.59

g/l

0.08

1495

9526

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1171

7179

1.16

5.45

1.4

1.5

27.16

19.06

u/ml

0.73

143

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

160

758

1.50

5.41

1.1

1.3

105.33

107.67

0.41

146

722

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

640

3725

1.22

5.40

1.1

98.14

95.41

1.75

597

3497

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.76

5.37

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

420

1.67

5.33

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

183

894

1.45

5.32

1.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

205

1.97

5.22

1.0

25.14

17.70

u/ml

0.41

168

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

561

3236

1.23

5.18

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

582

3372

1.23

5.16

15.6

6.3

7.24

7.29

mmol/l

0.07

484

2748

(3023420) DNA double strand Ab [Units/volume] in Serum

628

3667

1.22

5.16

1.7

1.6

30.65

34.84

iu/ml

0.38

164

(3007700) Barley IgE Ab [Units/volume] in Serum

158

2.11

5.15

1.0

0.46

9.82

u/ml

0.50

(3012494) Peanut IgE Ab [Units/volume] in Serum

216

1095

1.40

5.14

1.1

43.13

10.34

u/ml

0.36

130

628

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

809

4839

1.19

5.13

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

215

1090

1.40

5.12

2.6

3.0

26.55

28.88

umol/l

1.99

156

835

(3035320) C reactive protein [Mass/volume] in Body fluid

412

2300

1.27

5.08

2.8

2.3

—

(3006270) Folate [Moles/volume] in Blood

436

2452

1.26

5.06

1.1

1.2

397.77

372.22

nmol/l

1.95

409

2066

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

368

1.70

5.03

1.0

1.1

1.25

2.02

u/ml

0.33

277

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

222

1136

1.39

5.02

1.1

1.0

10.53

12.26

u/ml

0.49

125

656

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2741

17785

1.10

4.96

6.8

7.1

24.58

24.59

mmol/l

0.07

2644

16872

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

224

1.90

4.96

1.0

0.45

2.02

u/ml

1.29

174

(3018001) Oat IgE Ab [Units/volume] in Serum

241

1.85

4.85

1.0

0.25

0.80

u/ml

0.71

142

(3027974) Hepatitis B virus e Ag [Presence] in Serum

196

1.95

4.85

1.5

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

617

3627

1.21

4.77

2.4

2.3

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

462

2636

1.24

4.76

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

131

613

1.52

4.75

1.8

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

166

816

1.44

4.73

1.2

1.4

16.76

16.88

umol/l

0.12

149

728

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1373

8607

1.13

4.69

1.4

1.5

11.90

15.16

iu/ml

0.67

207

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

333

1830

1.29

4.69

1.2

25.70

22.93

u/l

0.39

279

1592

(3038026) Centromere Ab [Units/volume] in Serum

444

2527

1.25

4.69

1.2

32.05

50.34

u/ml

0.52

122

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

151

731

1.47

4.66

1.1

1.2

97.53

87.62

0.87

209

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

170

842

1.43

4.66

2.5

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

170

842

1.43

4.66

2.5

2.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

460

2632

1.24

4.64

1.2

—

(4035726) Immunohistochemistry procedure

3525

26889

0.92

4.64

1.4

—

(3019977) pH of Arterial blood

283

1524

1.32

4.63

2.7

2.5

7.42

0.10

535

(3033923) Metanephrine [Moles/time] in 24 hour Urine

136

646

1.49

4.61

1.1

1.27

2.83

umol/24h

0.32

329

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

460

2634

1.24

4.61

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

581

3412

1.21

4.56

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

433

2467

1.25

4.55

1.2

51.33

43.91

u/ml

0.27

186

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

432

2461

1.25

4.54

1.2

61.82

70.21

u/ml

0.27

113

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

106

2.27

4.49

2.1

2.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

138

662

1.48

4.48

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

138

663

1.48

4.45

1.1

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

415

2361

1.25

4.43

1.2

5.63

10.94

u/ml

0.82

163

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

138

664

1.47

4.42

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

418

2384

1.24

4.37

1.3

1.4

11.05

12.02

umol/l

2.17

396

2262

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

454

2613

1.23

4.37

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

149

731

1.45

4.33

1.1

1.2

80.61

75.79

0.28

200

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

732

4412

1.18

4.33

1.1

1.48

1.49

g/l

0.30

666

3996

(40759836) Histone Ab [Presence] in Serum by Immunoblot

453

2610

1.23

4.32

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

338

1884

1.27

4.30

1.2

87.32

88.64

u/l

0.08

288

1663

(3030313) Adrenal Ab [Titer] in Serum

347

1.66

4.30

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

151

744

1.44

4.29

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

453

2617

1.23

4.22

1.2

—

(3036603) Volume of Urine

362

2040

1.26

4.22

1.5

1.6

2085.95

1958.62

1.62

357

1984

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

968

5978

1.15

4.19

1.2

142.86

129.85

titre

—

130

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

300

1659

1.28

4.09

1.1

1605.67

1496.47

miu/ml

0.86

300

1659

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

835

5113

1.16

4.07

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1145

7169

1.13

4.05

1.6

9548.37

13564.81

e6/l

3.73

823

5246

(3035947) Staphylolysin Ab [Units/volume] in Serum

278

1525

1.29

4.04

1.1

3.82

3.63

iu/ml

0.15

120

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

157

790

1.41

4.01

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

226

1207

1.33

3.99

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

796

0.61

3.97

1.3

3.61

3.37

mmol/l

0.21

732

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

274

1.71

3.96

1.1

—

(3000330) Specific gravity of Urine by Test strip

1921

14931

0.91

3.95

3.0

3.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

809

4955

1.16

3.95

1.3

1.4

6.89

7.04

mmol/l

0.82

748

4387

(3051387) C reactive protein [Mass/volume] in Capillary blood

833

6795

0.87

3.92

3.8

3.2

22.20

26.35

mg/l

2.80

478

4270

(3013945) Hepatitis B virus e Ab [Presence] in Serum

192

1.85

3.88

1.5

1.4

—

(3007542) Rye IgE Ab [Units/volume] in Serum

182

1.87

3.87

1.0

0.51

10.87

u/ml

0.49

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

244

1.74

3.87

1.0

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

172

1.90

3.87

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

397

1.57

3.84

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

251

1370

1.30

3.82

2.5

2.4

52.68

51.70

umol/l

0.18

214

1188

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

171

883

1.37

3.78

1.4

1.6

9.29

8.99

ug/l

0.35

171

883

(3032057) Clostridioides difficile [Presence] in Stool

123

599

1.46

3.77

1.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1366

8687

1.12

3.76

3.9

4.0

1.38

1.47

mg/l

3.85

1262

8051

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

150

765

1.39

3.59

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

235

1.72

3.54

1.1

14.72

7.35

u/ml

0.96

169

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

135

680

1.41

3.49

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

125

621

1.43

3.48

1.3

1.2

87.18

41.15

mg/l

0.39

445

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1235

7854

1.12

3.44

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

790

4886

1.15

3.43

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

140

712

1.39

3.43

1.6

0.41

0.39

ug/l

0.17

468

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

455

1.50

3.41

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

558

3363

1.18

3.40

2.7

3.3

3.91

7.49

nmol/l

1.37

539

3258

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.48

3.40

1.2

2.8

2.29

2.38

mu/l

0.03

(3020123) Porphyrins [Interpretation] in Serum or Plasma

193

1.76

3.28

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

335

1934

1.23

3.25

1.6

6.27

6.81

u/l

0.31

259

1554

(3016273) Islet cell 512 Ab [Units/volume] in Serum

253

1.65

3.22

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

231

0.37

3.20

1.1

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

104

509

1.45

3.18

2.0

2.1

1.20

1.19

mmol/l

0.25

485

(3036071) Salmonella sp Ab [Titer] in Serum

205

1120

1.30

3.17

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

360

1.54

3.16

5.9

7.8

—

(3013466) aPTT in Blood by Coagulation assay

206

1.72

3.16

1.2

1.1

35.41

36.50

0.76

175

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

853

5343

1.13

3.11

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

688

0.64

3.10

1.3

97.47

309.40

ug/l

1.76

369

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

257

1.63

3.05

1.2

16.69

15.44

nmol/l

0.18

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

353

2068

1.21

3.00

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1329

10350

0.91

2.95

3.0

3.5

299.44

1953.31

u/ml

1.89

1125

8878

(3016031) Almond IgE Ab [Units/volume] in Serum

254

1.62

2.95

1.0

1.1

0.44

0.73

u/ml

0.77

154

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

266

2329

0.81

2.94

1.3

472.43

531.26

u/l

0.21

250

2209

(3013247) Albumin in CSF/Albumin in Serum or Plasma

148

782

1.34

2.93

1.1

6.49

6.97

mg/g

0.29

143

741

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

374

1.50

2.88

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

228

1282

1.26

2.86

1.1

1264.76

477.37

ng/l

0.33

293

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

548

3354

1.16

2.83

1.3

1.4

8.45

8.04

mmol/l

1.25

536

3235

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

475

1.43

2.81

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

186

1022

1.29

2.81

2.3

2.2

170.76

358.06

e6/l

1.49

105

561

(40768793) Breast Pathology biopsy report

1139

7303

1.11

2.81

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

417

1.46

2.80

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

404

3380

0.85

2.77

1.5

33.27

33.44

g/l

0.10

362

3058

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

209

1.66

2.77

1.0

1.04

0.45

u/ml

0.40

191

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

372

1.49

2.76

1.9

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1526

11768

0.92

2.76

4.6

5.1

0.91

0.90

0.18

1441

11006

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

395

3307

0.85

2.74

1.9

27.94

24.04

ug/l

0.26

386

3233

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

174

1.71

2.65

1.1

1.07

1.21

u/field

0.72

116

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.04

2.65

1.1

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.19

2.65

1.2

1.5

193.75

121.18

nmol/l

0.96

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

134

710

1.34

2.64

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

479

0.61

2.62

5.7

7.0

—

(40765096) Chromosome analysis panel by Banding

844

0.71

2.59

1.1

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

207

1166

1.26

2.59

1.2

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.05

2.59

1.0

0.33

0.90

u/ml

0.89

(3001893) Eosinophils/100 leukocytes in Pleural fluid

777

0.69

2.59

1.4

3.27

2.84

0.16

652

(3016750) Collection duration of Urine

199

1768

0.80

2.57

2.0

2.2

509.42

499.34

min

0.75

139

1346

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

449

1.42

2.56

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

822

5209

1.12

2.55

1.1

81.06

2684.21

iu/ml

0.79

200

1201

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

226

1289

1.24

2.55

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

153

833

1.30

2.52

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

369

1.46

2.50

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1563

11981

0.92

2.49

4.5

5.0

1.85

1.69

4.29

1475

11203

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

446

1.42

2.48

1.6

1.4

261434.14

199185.53

nmol/l

0.12

365

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1183

7657

1.10

2.46

1.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

223

0.44

2.46

3.3

6.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

232

0.46

2.44

1.1

1.0

—

(3017569) Oxygen content in Arterial blood

215

1227

1.24

2.43

2.5

2.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

639

0.68

2.40

1.4

21.96

23.43

0.15

536

(3004541) Aldosterone [Moles/volume] in Urine

7.09

2.37

1.4

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

218

1251

1.24

2.36

3.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

117

621

1.34

2.33

1.4

1.3

—

(3024263) Appearance of Synovial fluid

260

1522

1.21

2.33

1.5

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

269

1580

1.21

2.32

1.2

1.1

22.45

24.40

u/l

0.22

245

1429

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

103

537

1.36

2.30

1.3

1.4

54.20

256.74

ng/l

0.71

346

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

445

2734

1.15

2.27

1.2

230.00

190.70

titre

—

100

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

446

2742

1.15

2.25

1.2

191.82

194.50

titre

0.02

458

(3042628) Porphyrins [Moles/volume] in Urine

4.14

2.24

1.1

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

746

0.71

2.24

12.3

8.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

228

1.55

2.23

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

268

1581

1.20

2.23

1.2

1.1

80.37

84.59

u/l

0.35

243

1429

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

150

830

1.28

2.23

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.27

2.22

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

224

1299

1.22

2.22

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

430

0.63

2.19

3.6

3.0

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

236

1.53

2.15

1.9

3.2

14.22

10.86

0.31

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

905

7046

0.91

2.11

2.1

2.3

113.19

109.37

ug/min

0.08

528

4260

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

253

1494

1.20

2.11

1.1

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

3.82

2.10

1.0

—

(40768806) Pleura Pathology biopsy report

314

2611

0.85

2.10

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1886

12530

1.07

2.10

3.8

3.9

51.50

48.51

5.63

1863

12397

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2355

15758

1.06

2.10

8.7

10.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

107

571

1.33

2.09

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

168

0.42

2.06

1.1

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

615

3891

1.12

2.04

1.2

1.1

0.79

2.07

iu/ml

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

253

2136

0.84

2.04

1.5

1.7

—

(3028433) Virus identified in Specimen by Culture

182

1044

1.24

2.03

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

257

1.49

2.02

1.4

7.70

14.22

pmol/l

1.54

220

(3000034) Microalbumin [Mass/volume] in Urine

435

2697

1.14

2.00

3.1

3.0

48.85

54.68

mg/l

0.22

313

1916

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

388

1.39

1.98

1.6

1.7

1.65

1.73

mg/l

0.19

327

(3013862) HLA-DP [Type]

135

0.42

1.97

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

213

0.50

1.97

1.1

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

621

0.71

1.97

1.0

1.4

—

(4281824) Cell count and differential, peritoneal fluid

428

3459

0.88

1.97

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

339

2070

1.16

1.93

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5377

36796

1.04

1.93

4.3

4.2

31.96

32.18

0.78

3888

26094

(3024471) HLA-A [Type]

138

1230

0.79

1.93

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

230

1361

1.20

1.91

2.6

2.7

112.69

162.72

au/ml

1.27

181

(40759632) Porphyrins [Mass/mass] in Stool

2.52

1.89

1.3

1.1

—

(40757373) Influenza virus identified in Isolate

599

0.71

1.89

1.4

1.5

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

495

1.33

1.88

1.8

42.71

58.43

pmol/l

0.43

420

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

520

1.32

1.87

1.0

1.1

—

(40760409) HLA-A [Type] by High resolution

132

0.43

1.85

1.0

—

(40760410) HLA-B [Type] by High resolution

132

0.43

1.85

1.0

—

(3016330) Potassium [Moles/time] in 24 hour Urine

491

1.33

1.84

1.4

1.2

88.69

75.39

mmol/24h

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

228

1354

1.19

1.83

3.5

5.5

3707.83

2376.21

mg/l

0.31

161

979

(3035880) pH of Pleural fluid

161

1400

0.81

1.82

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

652

0.73

1.82

13.1

8.3

—

(3024932) HLA-DR beta [Type]

136

1204

0.80

1.81

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

299

1.42

1.81

1.1

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

389

1.37

1.81

2.3

2.6

—

(3017704) Immunofixation for Urine

175

1508

0.82

1.81

1.5

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

145

825

1.25

1.78

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

148

845

1.24

1.77

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1462

11066

0.93

1.76

2.0

1.84

2.32

ug/l

1.05

1295

9769

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

337

0.63

1.74

1.3

31.30

279.98

u/l

1.13

243

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.93

1.74

1.0

2.92

0.36

u/ml

0.45

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

314

1.40

1.73

1.1

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

952

6218

1.09

1.73

2.4

2.2

0.86

0.84

nmol/l

0.35

799

5223

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

218

1832

0.84

1.73

1.3

12.81

14.41

u/l

0.70

202

1686

(3033942) Copper [Moles/time] in 24 hour Urine

152

1.59

1.72

1.2

1.23

0.82

umol/24h

0.24

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

238

1.46

1.71

1.1

17.09

23.20

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

238

1.46

1.71

1.1

31.89

29.50

u/ml

—

(3006245) CD3-CD19+ cells/100 cells in Blood

229

1371

1.18

1.71

2.4

2.3

10.06

10.66

0.33

220

1276

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

248

1495

1.18

1.71

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6365

46461

0.97

1.70

2.8

0.66

0.74

ug/l

5.93

3877

28500

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

380

2366

1.14

1.70

2.1

2.6

558.33

524.18

e6/l

0.44

304

1987

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.11

1.69

1.1

1.0

0.04

0.23

u/ml

—

(3000012) Reticulocyte production index

594

3800

1.11

1.68

2.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

106

0.40

1.68

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

143

1246

0.81

1.67

5.1

5.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

675

4350

1.10

1.66

1.4

—

(3020491) Glucose [Moles/volume] in Blood

392

2450

1.14

1.66

1.6

1.8

6.57

6.64

mmol/l

0.18

316

1801

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

103

568

1.29

1.66

2.3

2.6

35.81

49.82

mg/l

0.39

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

390

1.35

1.64

2.1

2.6

1.29

1.35

mmol/l

0.07

270

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.72

1.64

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

282

1.41

1.63

1.1

1.0

6.60

4.20

u/ml

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

229

1.46

1.63

1.3

1.5

41.58

36.23

0.40

154

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

452

2855

1.12

1.62

1.5

33.47

31.96

0.36

272

1789

(3047181) Lactate [Moles/volume] in Blood

1435

9547

1.07

1.61

4.7

5.7

1.32

1.29

mmol/l

0.37

1278

8427

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

164

1400

0.83

1.58

3.2

3.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

214

1.46

1.55

1.0

1.1

9.00

9.06

u/l

0.01

214

(3045788) Cell count panel - Pleural fluid

289

2352

0.87

1.55

1.5

—

(3022670) pH of Venous cord blood

1.88

1.54

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

386

0.68

1.54

1.4

13.00

12.70

0.02

197

(40763590) HLA-DQ beta [Type]

132

0.48

1.54

1.0

—

(46236302) HLA-C [Type] by High resolution typing

133

0.48

1.53

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

322

1.37

1.53

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

722

5576

0.92

1.52

1.5

1.6

—

(3012441) Differential panel - Pleural fluid

326

2627

0.88

1.52

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

558

0.74

1.52

1.1

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

172

1017

1.20

1.51

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

367

2302

1.13

1.50

2.2

2.7

0.22

0.23

e9/l

0.11

303

1988

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

307

1904

1.14

1.50

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

174

1032

1.20

1.49

1.7

163.39

133.89

au/ml

0.26

138

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1022

6744

1.08

1.48

4.3

6.1

6106.22

1138.41

iu/ml

0.43

114

1005

(3023199) Leukocytes [#/volume] in Pleural fluid

384

3057

0.89

1.48

1.5

3883.03

3416.87

e6/l

0.21

265

2216

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

170

1.50

1.47

1.2

1.4

2.11

1.61

0.20

111

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

144

840

1.22

1.47

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

481

0.72

1.46

1.7

2.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

182

1.48

1.46

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

287

0.64

1.44

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

127

733

1.23

1.44

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

127

733

1.23

1.44

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

127

733

1.23

1.44

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

127

733

1.23

1.44

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

244

1494

1.16

1.44

3.2

8.41

8.10

mg/l

0.25

191

1201

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

787

5150

1.08

1.43

1.4

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

213

1292

1.17

1.42

1.9

2.0

9.29

mg/l

0.00

169

1033

(3023487) Leukocytes [#/volume] in Peritoneal fluid

118

1024

0.82

1.39

2.0

657.70

2919.75

e6/l

1.49

693

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

134

782

1.22

1.38

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

185

1539

0.85

1.37

23.5

27.9

110.78

119.44

ug/l

1.00

152

1278

(3000093) Morphology [Interpretation] in Blood Narrative

445

2842

1.11

1.37

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1071

7105

1.07

1.37

1.5

1.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

133

1.55

1.37

1.1

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.66

1.36

1.0

—

(36303858) Crystals [Presence] in Urine

2.03

1.34

1.0

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

104

910

0.81

1.33

1.4

57.11

62.16

0.80

743

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

190

1150

1.17

1.32

1.1

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.69

1.32

1.0

0.05

0.09

u/ml

0.43

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

246

0.63

1.32

3.1

2.2

73.00

58.01

—

151

(3026250) Tacrolimus [Mass/volume] in Blood

195

1606

0.86

1.29

37.5

36.7

7.43

7.39

ug/l

0.12

183

1463

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

218

1337

1.16

1.29

2.1

2.2

26.93

29.41

2.29

211

1268

(3028308) Erythrocytes [#/volume] in Pleural fluid

349

2764

0.89

1.27

1.5

1.4

63093.27

50362.54

e6/l

0.18

200

1634

(40758292) HTLV I+II Ab panel - Serum

581

0.77

1.27

1.3

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

502

1.26

1.27

1.0

0.33

0.23

u/ml

0.12

306

(3022475) Manganese [Moles/volume] in Blood

200

1.42

1.27

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

224

1.39

1.26

1.1

3.21

1.28

u/ml

0.85

156

(3011325) HIV 1+2 Ab [Presence] in Serum

165

1.46

1.26

1.1

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

777

5116

1.08

1.25

2.5

3.1

3154.00

6061.52

u/ml

0.42

289

(3033799) Differential panel - Peritoneal fluid

100

870

0.81

1.24

2.2

1.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3381

23164

1.04

1.24

2.5

2.9

162.18

188.01

ng/l

2.99

3055

20977

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

678

4447

1.08

1.21

1.3

30.13

34.94

u/l

0.32

597

3877

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

312

1970

1.12

1.21

1.3

1.4

5.51

5.57

mmol/l

0.39

293

1866

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

330

1.31

1.21

1.0

1.1

1.69

2.82

umol/24h

0.51

330

(3047189) Immunofixation for 24 hour Urine

145

1215

0.85

1.21

1.7

1.9

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.62

1.21

1.2

—

(3008896) Cortisol [Moles/volume] in Urine

2.73

1.21

1.2

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

500

3238

1.10

1.20

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

395

2529

1.11

1.20

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

395

2529

1.11

1.20

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

395

2529

1.11

1.20

1.5

1.7

—

(3044007) Cell count panel - Peritoneal fluid

818

0.81

1.18

1.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

396

0.73

1.16

1.2

1.3

1.73

1.43

mmol/l

0.09

253

(3018133) Calcium [Moles/volume] in Urine

566

1.23

1.16

2.2

2.1

2.27

2.73

mmol/l

1.60

514

(3044927) Protein electrophoresis panel - Urine

336

2649

0.90

1.16

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1701

11506

1.05

1.16

1.9

1.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

522

1.24

1.15

1.2

1.3

51.11

173.49

titre

—

(42870560) Thyrotropin [Units/volume] in Cord blood

168

0.59

1.15

1.0

12.10

8.33

mu/l

1.16

140

(3001729) Color of Synovial fluid

237

0.66

1.14

2.5

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

197

1213

1.15

1.14

2.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

128

761

1.19

1.14

1.2

253.33

561.08

titre

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

229

1.36

1.14

1.5

1.8

52.82

45.87

umol/l

0.51

229

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

271

1706

1.13

1.5

1.7

2.34

2.43

u/field

0.07

205

1223

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.95

1.13

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

372

1.28

1.12

2.2

3.3

41.47

41.85

umol/l

0.05

322

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

176

1.41

1.11

1.0

1.1

61.25

54.97

u/l

0.19

140

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.77

1.11

1.1

33.50

26.98

umol/24h

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

336

1.29

1.09

1.6

1.5

110.27

114.55

ug/l

0.11

274

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

360

2309

1.11

1.09

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1860

12634

1.05

1.08

2.0

1.9

—

(3029612) Listeria sp Ab [Titer] in Serum

1.65

1.07

1.4

1.3

—

(3011412) CD3 cells [#/volume] in Blood

497

3240

1.09

1.07

2.2

2.5

1.33

1.21

e9/l

1.66

428

2899

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.16

1.05

1.1

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

627

0.80

1.05

1.7

2.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

137

1136

0.85

1.05

1.5

1.7

9296.36

29476.83

u/ml

0.72

138

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

320

1.29

1.03

2.2

—

(3019174) dRVVT (LA screen)

314

1.29

1.03

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

710

0.82

1.02

1.5

1.4

13.05

13.60

g/l

0.22

538

(3045142) Bone marrow Pathology biopsy report

404

3128

0.91

1.01

1.2

1.3

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

204

1.36

1.00

1.4

1.5

11.97

12.93

0.10

147

(3001218) Citrate [Mass/time] in 24 hour Urine

1.86

1.00

1.5

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

139

844

1.17

1.00

1.1

—

(4146454) Self-monitoring of blood glucose

395

3060

0.91

1.00

2.6

2.8

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

816

0.83

0.99

1.7

1.9

32.87

36.03

u/l

0.07

738

(3004809) Band form neutrophils/100 leukocytes in Blood

640

4859

0.93

0.98

2.7

3.2

1.49

1.52

0.10

561

4340

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1025

6883

1.06

0.97

1.5

1.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.82

0.97

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

349

1.26

0.96

5.7

5.0

52.54

55.54

g/mol

0.06

318

(3028468) Fragments [Presence] in Blood by Light microscopy

2.36

0.96

3.5

1.7

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.68

0.95

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

522

3434

1.08

0.94

1.4

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

522

3434

1.08

0.94

1.4

1.6

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.24

0.93

1.0

1.1

21.17

14.79

umol/l

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

436

0.78

0.93

7.6

6.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

207

1.34

0.93

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

128

1054

0.86

0.93

1.4

1.5

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.60

0.91

1.5

1.1

—

(3018572) Chloride [Moles/volume] in Blood

882

6608

0.95

0.91

5.9

6.8

104.78

105.19

mmol/l

1.58

813

5928

(3039000) Anion gap in Blood

882

6607

0.95

0.91

5.9

6.8

11.49

11.18

mmol/l

1.92

813

5926

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

224

0.70

0.90

2.2

2.7

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

397

1.23

0.90

2.9

3.0

24.25

23.12

mg/l

0.32

375

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

2.13

0.90

1.7

1.1

—

(3037121) Protein [Mass/volume] in Urine

1555

10579

1.04

0.89

3.0

3.3

0.26

0.32

g/l

2.04

644

4759

(3035060) Mercury [Moles/volume] in Blood

1.77

0.89

2.5

1.4

19.60

9.38

nmol/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

198

0.68

0.88

1.0

—

(3012565) Volume of 24 hour Urine

245

1565

1.11

0.86

2.1

2.2

1996.04

1984.97

0.05

218

1409

(3003577) Lead [Moles/volume] in Blood

260

1.28

0.86

1.7

1.4

0.21

0.22

umol/l

0.09

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

155

1.37

0.86

1.0

0.06

0.16

u/ml

0.81

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.70

0.86

1.1

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

387

1.23

0.86

2.9

3.1

—

(40762365) Oxygen content in Arterial blood by calculation

471

1.20

0.85

2.7

3.0

15.20

14.82

ml/dl

0.53

440

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

109

901

0.86

0.85

1.9

13106.52

11029.99

e6/l

0.10

473

(3026480) Teichoate Ab [Titer] in Serum

248

1.29

0.85

1.1

—

2.91

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

464

3054

1.08

0.85

1.4

1.5

—

(40758358) Immune stain study

145

0.64

0.84

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

260

1669

1.10

0.84

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

230

1.29

0.83

3.1

2.8

12.66

407.59

pmol/l

0.66

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

199

1.32

0.83

1.3

1.4

19.99

16.52

pmol/l

0.26

168

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

170

0.67

0.83

1.1

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.93

0.83

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

741

4962

1.06

0.82

1.5

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

234

1497

1.11

0.81

1.4

1.5

4.02

3.91

0.04

343

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

741

4964

1.06

0.81

1.5

1.7

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.67

0.81

1.0

422.80

358.49

umol/l

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.72

0.80

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

103

1.45

0.80

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.79

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.79

0.0

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

199

1265

1.12

0.78

2.5

2.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

377

2886

0.93

0.78

1.4

—

(21494434) Karyotype in Bone marrow

309

2384

0.92

0.77

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

755

0.85

0.77

1.2

1.3

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

1.72

0.76

1.0

—

0.05

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

413

1.20

0.75

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

280

0.76

0.75

1.0

1.1

22.18

21.21

u/l

0.11

188

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

227

1458

1.10

0.75

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

2.08

0.74

1.0

1.1

24.00

32.53

umol/l

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.55

0.73

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

507

3373

1.07

0.72

1.5

1.6

7.56

7.66

mmol/l

0.53

493

3229

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

559

1.17

0.72

2.1

2.4

6.63

7.52

mmol/l

1.85

335

(1175426) CD3 cells/100 lymphocytes in Blood

394

2599

1.08

0.72

2.2

2.1

74.59

72.80

1.89

380

2501

(3035153) Lemon IgE Ab [Units/volume] in Serum

1.97

0.71

1.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.69

0.71

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

313

1.22

0.70

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

422

2794

1.07

0.70

1.4

115085.01

102993.91

e6/l

0.14

298

1901

(3048879) Bone marrow aspiration report

785

0.87

0.69

1.4

1.9

—

(3023419) Bacteria identified in Sputum by Culture

630

4229

1.06

0.68

2.4

2.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

601

4029

1.06

0.68

1.4

1.5

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.45

0.68

1.0

0.01

0.20

u/ml

0.81

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

321

1.21

0.68

1.0

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

365

2408

1.07

0.68

2.2

2.1

—

(3012516) Albumin [Mass/volume] in Urine

12140

85127

1.01

0.68

3.1

3.3

479.56

417.07

mg/l

0.65

7750

54116

(3009015) Lactate [Moles/volume] in Synovial fluid

296

1.22

0.67

1.1

1.3

5.21

6.24

mmol/l

0.66

144

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

138

1.34

0.67

1.0

0.06

0.09

u/ml

0.12

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

305

2000

1.08

0.67

6.2

6.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

249

1922

0.92

0.66

2.6

2.7

42.69

39.64

1.88

133

1060

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

337

0.80

0.66

2.3

3.0

2.38

1.13

mg/l

1.00

219

(3000285) Sodium [Moles/volume] in Blood

348

1.20

0.66

1.2

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

182

1.29

0.66

1.0

1.1

2.96

2.77

u/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

217

1403

1.10

0.66

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

370

2446

1.07

0.66

2.2

2.6

795.19

687.76

e6/l

2.65

355

2373

(4212803) Bone marrow aspirate examination

239

1.25

0.66

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

220

1.26

0.66

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

114

1.37

0.65

1.0

1.1

0.19

0.21

g/l

0.93

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

514

0.84

0.65

2.4

2.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

265

1.23

0.65

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

339

2237

1.07

0.64

1.6

1.5

—

(3024316) Viscosity of Plasma

146

1.31

0.62

1.9

1.6

1.83

1.51

mpas

0.89

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

386

2563

1.07

0.62

2.1

13.10

14.83

3.68

378

2494

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1201

8210

1.04

0.62

2.7

3.3

7.08

3.85

ratio

0.31

110

627

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.0

—

0.09

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

223

0.76

0.61

1.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.61

0.61

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.61

0.61

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.61

0.61

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.61

0.61

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.61

0.61

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.61

0.61

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

207

0.75

0.61

2.8

2.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

435

3273

0.94

0.60

3.0

3.6

—

(3022689) Creatine [Moles/volume] in Urine

139

884

1.11

0.60

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

889

6050

1.04

0.58

1.4

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

641

4331

1.05

0.58

2.8

132.52

509.17

u/ml

0.95

631

4277

(3002619) Bacteria identified in Specimen by Culture

103

646

1.13

0.57

1.3

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

131

0.70

0.56

1.2

1.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

303

1.19

0.56

1.2

20.89

20.92

mmol/l

0.02

238

(3019768) Coxiella burnetii Ab [Presence] in Serum

187

1.25

0.56

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

547

1.14

0.56

4.5

6.0

69.10

69.40

0.04

424

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.46

0.55

2.2

2.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

125

795

1.11

0.55

2.3

2.6

112.98

104.14

ng/l

0.28

424

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.52

0.55

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

235

1542

1.08

0.54

1.6

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

135

1059

0.90

0.54

3.0

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

135

1058

0.90

0.54

6.0

6.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

154

0.74

0.53

1.0

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

331

1.18

0.53

1.1

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.42

0.52

1.7

1.4

1.58

2.24

mmol/24h

1.92

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

193

0.77

0.52

5.9

5.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

359

1.17

0.51

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

505

1.14

0.51

1.5

1.6

—

(46235168) Fasting glucose [Moles/volume] in Blood

424

0.85

0.50

1.1

1.8

6.09

7.41

mmol/l

1.73

138

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

288

1913

1.07

0.50

1.4

12.35

12.50

u/l

0.14

281

1849

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.37

0.50

1.1

—

(3037756) Immunofixation for Serum or Plasma

761

5608

0.96

0.49

1.5

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

435

2927

1.05

0.49

2.2

41.87

38.59

4.90

427

2876

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

702

5181

0.96

0.49

2.9

3.6

38.41

37.62

u/ml

0.03

676

5001

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.38

0.49

1.3

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

427

3188

0.95

0.49

2.4

2.6

1.20

1.34

g/24h

0.51

190

1637

(3027923) C peptide [Moles/volume] in Serum or Plasma

256

1695

1.07

0.49

1.7

1.6

1.23

1.25

nmol/l

0.07

196

1350

(3049233) Organic acids panel - Urine

1.47

0.49

1.3

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1229

8453

1.03

0.49

2.8

3.4

38.96

41.59

mg/l

0.17

971

6851

(3034860) Kappa light chains.free [Mass/volume] in Serum

1231

8468

1.03

0.48

2.8

3.4

42.50

67.87

mg/l

1.94

969

6864

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

222

0.80

0.48

9.2

4.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.34

0.47

1.1

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

291

0.83

0.47

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

303

2281

0.94

0.47

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

390

2621

1.06

0.47

1.5

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

223

1472

1.07

0.47

1.2

1.3

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.46

0.47

1.1

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

376

1.15

0.46

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

225

1.20

0.46

1.4

1.2

118.00

104.45

ug/l

0.20

139

(3003129) Base excess in Capillary blood by calculation

742

0.90

0.45

1.7

1.13

0.56

mmol/l

0.88

696

(21494890) Protein electrophoresis panel - 24 hour Urine

374

2794

0.95

0.45

1.9

2.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

184

1406

0.93

0.45

2.2

2.1

38.21

110.91

ug/min

2.81

317

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.69

0.44

1.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1973

13685

1.02

0.44

3.4

3.5

25.10

25.28

mmol/l

1.65

1903

13266

(3034614) HLA Ag [Interpretation]

1.35

0.44

1.0

1.3

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

123

1.27

0.43

1.0

1.3

0.92

1.16

u/field

0.61

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

387

0.86

0.43

1.9

2.3

0.68

0.65

u/field

0.06

387

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

635

0.89

0.43

1.3

1.2

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.42

0.42

1.6

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.31

0.42

2.7

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.42

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

150

1.23

0.41

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

170

0.79

0.41

3.2

3.5

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

170

0.79

0.41

1.2

1.3

18.07

1120.12

u/l

1.46

150

(3026470) Cobalt [Mass/volume] in Blood

215

1625

0.94

0.40

2.0

3.54

3.68

ug/l

0.11

202

1480

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

880

6433

0.97

0.40

1.5

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

230

1532

1.06

0.40

1.6

1.5

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

203

1.19

0.39

1.8

181.66

176.52

ug/g

0.07

173

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

652

0.90

0.39

2.5

2.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1291

9376

0.98

0.38

3.4

3.3

0.35

u/ml

0.01

697

5349

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

105

0.74

0.37

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

326

2426

0.95

0.37

1.7

2.0

2.14

2.33

u/field

0.24

181

1072

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

139

1.22

0.37

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

165

1.20

0.37

1.0

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

120

1.24

0.36

1.0

1.1

2.15

1.05

u/field

0.35

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

351

1.13

0.36

1.1

—

(40768446) Kidney Pathology biopsy report

183

1383

0.94

0.36

1.9

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

153

1010

1.07

0.36

1.3

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

192

1.18

0.36

1.3

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

644

4717

0.97

0.35

3.6

3.1

0.80

0.81

nmol/l

0.30

502

3629

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

592

4055

1.04

0.35

1.5

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.31

0.35

5.6

0.20

0.22

mmol/l

0.15

(40762814) Titanium [Mass/volume] in Blood

461

0.89

0.35

2.3

3.02

3.91

ug/l

1.24

163

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

135

0.79

0.35

1.1

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

119

0.77

0.34

1.0

0.05

0.84

u/ml

—

(3009871) Measles virus Ab [Titer] in Serum

161

1218

0.94

0.34

1.7

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

153

1014

1.07

0.33

2.2

3.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

435

1.11

0.33

1.3

1.4

46.20

52.56

0.53

212

(3009677) Dengue virus Ab [Presence] in Serum

148

1.20

0.33

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

133

0.80

0.31

1.0

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

879

6391

0.97

0.31

2.8

3.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

215

1.15

0.31

1.3

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

322

1.12

0.31

1.4

1.6

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

110

1.22

0.31

1.0

1.1

185.71

227.84

pmol/l

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

559

3839

1.03

0.30

1.5

1.6

51.05

56.34

2.18

346

2459

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.27

0.30

1.0

—

(3025577) Chromium [Mass/volume] in Blood

212

1581

0.95

0.29

2.0

2.1

2.28

2.41

ug/l

0.21

179

1321

(3042631) Mycobacterium sp identified in Specimen

547

3759

1.03

0.29

2.7

2.6

—

(3018291) Platelet Ab [Presence] in Serum

1.34

0.29

1.1

1.0

—

(3005570) Glucose [Moles/volume] in Urine

459

3147

1.03

0.28

2.0

1.9

14.66

20.58

mmol/l

—

(3006576) Bicarbonate [Moles/volume] in Blood

150

1002

1.06

0.28

5.0

6.4

24.57

25.15

mmol/l

1.00

143

905

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.77

0.28

3.4

5.0

—

(3032641) Amino acids panel - Urine

1.26

0.28

1.5

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

611

1.08

0.27

2.0

1.8

2.47

3.50

ug/l

0.46

380

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

162

1214

0.95

0.27

1.7

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

162

1214

0.95

0.27

1.7

2.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

231

1.14

0.27

1.2

1.1

12.57

16.68

iu/ml

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.30

0.27

1.3

1.1

—

(40768441) Liver Pathology biopsy report

322

2372

0.96

0.27

1.2

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

432

2963

1.03

0.27

1.5

1.8

—

(3007916) DNA double strand Ab [Titer] in Serum

421

1.09

0.27

1.2

1.4

87.33

149.65

titre

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

481

0.91

0.26

1.2

1.78

1.72

mmol/l

0.09

293

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

145

0.83

0.26

3.4

3.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.31

0.26

1.4

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

610

4211

1.03

0.26

2.4

2.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

203

1508

0.95

0.26

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

242

0.88

0.25

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.28

0.25

1.1

2.45

2.59

0.12

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

492

1.08

0.24

4.3

4.8

42.58

45.88

ug/min

0.15

391

(3027035) Albumin [Mass/time] in 24 hour Urine

286

0.89

0.24

1.4

1.2

85.07

349.13

mg/24h

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

128

0.83

0.24

1.3

1.1

0.05

0.08

g/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

254

1872

0.96

0.24

1.3

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

367

0.91

0.24

1.3

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

295

1.11

0.23

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1359

9479

1.02

0.23

2.4

2.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

134

1002

0.95

0.23

2.1

2.0

—

(40768795) Lymph node Pathology biopsy report

425

3100

0.97

0.22

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

166

1233

0.95

0.22

1.7

2.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.26

0.22

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

127

0.84

0.22

1.5

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

537

3902

0.98

0.22

5.9

6.5

11.09

11.35

mg/l

0.67

497

3581

(3024869) Neuronal Ab [Presence] in Serum

536

1.07

0.22

1.1

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

712.50

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

545

3770

1.02

0.22

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

259

1903

0.96

0.22

1.2

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

502

3471

1.03

0.21

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

448

1.08

0.21

1.4

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

172

1273

0.96

0.21

2.2

2.0

—

(46235479) Bilirubin fractions panel [Moles/volume] - Serum or Plasma

0.00

0.21

0.0

1.1

—

41.80

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

134

904

1.05

0.20

1.5

1.4

46.48

54.72

1.68

113

772

(3041184) Isoniazid [Presence] in Urine

1.25

0.20

1.2

2.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

327

2249

1.03

0.20

1.8

1.9

3.36

3.71

mg/l

0.78

310

2148

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.22

0.20

1.0

1.3

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

157

1.13

0.19

1.6

172.40

199.52

ng/l

1.11

136

(21494567) Legionella sp IgM Ab [Presence] in Serum

225

1.10

0.18

1.3

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

463

0.93

0.18

1.1

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

139

0.87

0.18

2.9

3.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

514

1.06

0.18

1.1

3.57

3.62

pmol/l

0.01

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

101

0.84

0.17

3.0

3.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

177

1209

1.04

0.17

2.8

3.0

—

(3010503) CD19 cells [#/volume] in Blood

283

1950

1.03

0.17

2.2

2.7

0.16

0.32

e9/l

1.87

272

1904

(3027874) Urate [Moles/volume] in Urine

1.17

0.17

1.0

1.1

1.71

8.23

mmol/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

248

1706

1.03

0.17

1.3

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

145

1.12

0.16

1.5

0.33

0.16

u/l

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

410

0.93

0.16

7.8

9.3

0.34

0.41

umol/l

0.45

369

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

160

0.89

0.16

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

334

2425

0.98

0.15

1.2

1.3

6.42

6.28

mmol/l

0.39

307

2241

(3017958) Strawberry IgE Ab [Units/volume] in Serum

112

1.14

0.15

1.1

1.0

0.16

0.15

u/ml

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

108

800

0.96

0.15

1.3

44.55

39.14

0.73

540

(3026726) Creatinine [Moles/volume] in Specimen

235

1.09

0.15

2.3

2.4

487.81

397.64

umol/l

0.20

227

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

206

1417

1.03

0.15

1.3

1.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

208

1.09

0.14

1.1

1.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

206

1418

1.03

0.14

1.3

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

0.82

0.14

1.1

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

127

1.12

0.13

8.3

9.3

—

(3004959) Base excess in Arterial cord blood by calculation

168

1.10

0.13

1.0

-2.02

-2.03

mmol/l

—

(3016228) CD19 cells/100 cells in Blood

178

1299

0.97

0.13

2.2

2.0

8.78

8.49

0.14

171

1270

(3034426) Prothrombin time (PT)

176

1212

1.03

0.12

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

110

751

1.04

0.12

1.3

1.2

459.41

310.01

pmol/l

0.47

555

(3027570) Oxalate [Moles/time] in 24 hour Urine

210

1.08

0.12

1.4

1.5

310.59

317.55

umol/24h

0.07

210

(3002331) Protein [Mass/volume] in Peritoneal fluid

614

0.96

0.12

1.3

1.4

27.87

37.72

g/l

0.49

473

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

730

5111

1.01

0.11

1.6

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

349

1.06

0.11

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

229

0.93

0.11

1.1

1.2

23.20

23.51

—

(3006598) pH of Arterial cord blood

170

1.08

0.11

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

393

2743

1.02

0.10

2.7

2.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

469

1.04

0.10

1.2

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

330

1.05

0.10

3.2

2.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

109

1.11

0.10

1.2

1.1

229.69

262.62

nmol/l

0.36

109

(3017354) Segmented neutrophils/100 leukocytes in Blood

423

2956

1.01

0.09

2.7

3.2

56.35

56.58

0.08

347

2514

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.07

0.09

1.0

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

178

1.08

0.09

1.6

1.7

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

169

0.92

0.09

7.0

10.2

819.87

232.39

e6/l

0.36

120

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

132

0.91

0.09

1.0

0.01

0.25

u/ml

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.09

0.09

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

341

2382

1.01

0.08

1.0

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

172

1.07

0.08

1.4

1.3

2.13

1.56

mg/l

0.94

145

(3044316) Mercury [Moles/volume] in Urine

0.79

0.08

1.6

2.5

5.42

11.57

nmol/l

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

262

0.95

0.08

1.4

1.3

1.54

1.57

ml/s/173m2

0.03

171

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.90

0.08

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.77

0.08

1.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

686

0.97

0.08

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.06

0.08

1.0

1.1

941.43

2043.83

titre

—

(3050794) Legionella sp Ab [Presence] in Serum

277

1.05

0.08

1.2

1.1

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

189

0.94

0.07

1.1

1.2

—

438.57

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.05

0.07

4.5

4.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.08

0.07

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

12606

89488

1.00

0.06

3.7

3.9

8.50

9.39

mg/mmol

1.21

7897

56582

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

146

1.07

0.06

28.0

12.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

467

3342

0.99

0.06

1.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.90

0.06

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

629

1.03

0.06

6.0

5.6

—

(3008607) Semen analysis panel

317

0.96

0.06

1.3

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

461

1.03

0.06

1.1

1.3

33.85

42.58

mg/l

1.04

398

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

222

1552

1.01

0.06

1.6

1.9

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

234

1637

1.01

0.06

6.6

6.1

879.44

2997.08

u/ml

0.55

339

(3006462) Nitrate [Presence] in Urine

216

1552

0.99

0.06

2.6

3.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

561

3946

1.01

0.05

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

434

1.03

0.05

1.3

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

189

1.05

0.05

1.0

1.1

—

(3013762) Body weight Measured

136

0.94

0.05

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

243

1742

0.99

0.05

1.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

428

1.03

0.05

2.7

2.6

51.51

73.71

pmol/l

1.20

368

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

204

1.04

0.04

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

148

1.05

0.04

1.2

1.1

—

(3014891) Appearance of Pleural fluid

328

0.97

0.03

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

632

4501

1.00

0.03

1.5

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

119

855

0.99

0.03

1.2

1.3

38.90

39.86

g/l

0.31

468

(3020356) Listeria sp identified in Specimen by Organism specific culture

263

0.97

0.03

1.2

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

1.08

0.03

7.1

6.6

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.94

0.02

1.1

1792.83

4368.14

ng/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

200

1407

1.01

0.02

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

200

1407

1.01

0.02

1.6

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

176

0.97

0.02

1.5

1.8

0.69

umol/l

0.01

134

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

115

1.05

0.02

1.1

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

666

1.01

0.02

1.3

56.13

86.94

mu/l

1.00

499

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

120

843

1.01

0.02

1.2

—

(3014271) Vancomycin [Susceptibility]

191

1347

1.01

0.01

2.8

2.9

—

(3051593) INR in Capillary blood by Coagulation assay

171

1208

1.00

0.00

6.7

9.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.99

0.00

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

248

1.00

0.00

3.1

2.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

436

0.99

0.00

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

213

1.00

0.00

1.5

1.3

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.03

0.00

1.1

1.2

19.55

30.15

mg/l

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.05

0.00

1.0

1.1

0.91

1.33

u/field

0.75

(3033086) Enterovirus NOS Ab [Titer] in Serum

117

0.97

0.00

1.1

1.0

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

124

1.03

0.00

1.0

0.05

0.43

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

220

1557

1.00

0.00

1.6

1.9

—

(3004451) EKG impression Narrative

188

1336

1.00

0.00

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.97

0.00

7.5

8.4

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.97

0.00

2.5

2.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.84

0.00

1.4

1.3

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.84

0.00

1.4

1.3

—

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.95

-0.00

1.0

1.1

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.99

-0.00

1.0

1.1

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3039179) Angiotensin converting enzyme [Enzymatic activity/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.1

—

2.37

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_BEHAVE – Behavioural syndromes associated with physiological disturbances and physical factors

GWS hits: 7

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Behavioural syndromes associated with physiological disturbances and physical factors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints